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ABSTRACT 
As part of a larger program to make monoclonal 
antibodies to HLA-DP polymorphisms, the possibility of using 
immunomagnetism to replace some cumbersome procedures in 
hybridoma creation was investigated. In the first part of this 
study, metallic beads were coated with anti-DP capture 
antibody and then were used for immune absorption of DP 
molecules from cell lysates. The absorbed molecules were 
identified with the help of a fluorescent anti-DP antibody and 
flow cytometry. Optimum conditions for absorption of DP 
molecules onto beads were worked out. In the second part, the 
immunogenic prr:lperties of the purified DP molecules were 
tested, in which metallic beads coupled with absorbed 
molecules were injected into mice to provoke an immune 
response. Serum antibody corresponding to three different 
antigen doses was determined and showed that the strong 
antibody response was correlated with the large dose of 
antigen. The influence of beryllium sulphate and complete 
Freund's adjuvant on these antibody responses was compared. In 
the final part of the study, immune spleen cells were sorted 
by using goat anti-mouse IgG coated metallic beads andjor 
antigen coupled beads. Following magnetic separation the 
selected spleen cells were fused with SP2/o myeloma cells 
iii 
without the detachment of the beads, using a centrifugal·· 
electrofusion technique. Hybridomas which secreted antibodies 
were examined for their specificity to DP polymorphisms. The 
frequency of positive hybridomas, in fusions of pre-selected 
cells, was compared with that of the fusion of unsorted cells 
(prior to selection) and with that of the remainder of the 
cells left behind after a sort. Once a variety of tissue 
culture problems had been resolved, there was preliminary 
evidence suggesting that pre-fusion selection of antigen-
specific cells can be a helpful and time-saving procedure. 
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Chapter 1 
INTRODUCTION 
The success of transplantation of organs or tissues 
depends largely upon having the graft donor and the recipient 
as closely matched ror tissue antigens as possible. In the 
case of blood transfusion this is a familiar situation, where 
the antigens on the red blood cells in the transfused blood 
need tc be matched with those of the recipient or, at the very 
least, compatible with the recipient. In the case of other 
tissues such as bone marrow, or of organs, the matching 
involves particularly a series of antigens that are found on 
most of the nucleated cell~ of the body. For convenience these 
antigens are typed using white blood cells, so they are also 
known as human leucocyte antigens {HLA) . The system of 
antigenic molecules which has the major effect on 
transplantation success is coded by genes on the short arm of 
chromosome 6 in the human. These genes are known as the major 
histocompatibility complex {MHC), and they are divided into 
MHC class I, comprising HLA-A, -B, -C and MHC class II, 
comprising HLA-·DR, -DQ and -DP. All the class II products are 
composed of two poJ..ypeptide chains, and both of them are 
.... "
•., 
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polymorphic. 
The HLA-DP system was the most recently discovered and 
was revealed in 1980 by use of the primed lymphocyte test 
(PLT) (Shaw et al. 1980). This test depends upon culturing 
white blood cells for several days and it is a cumbersome, 
specialized technique that was not easily adapt~d for use in 
a routine tissue typing laboratory; it remained in the 
research domain. However, it seemed likely that these 
polymorphic molecules were important determinants of 
transplantation outcome and so a serological typing method was 
highly desirable. 
Our laboratory in Memorial University of Newfoundland 
decided to attempt to make mcnoclonal antibodies to the 
polymorphism of HLA-DP using a mouse system. In the 1980's the 
fact that HLA-DP can be recognized serologically was shown by 
the work of Heyes et al. (1986) who made a mouse monoclonal 
antibody to HLA-DP and by Johnson (1986) who raised an allo-
antiserum in a human volunteer by deliberate immunization. 
Since those promising beginnings there has not been much 
progress, despite the efforts of many laboratories. It turns 
out that the production of antibodies to HLA, especially to 
HLA-DP is a difficult und•ertaking. 
There are several problems involved in making 
monoclonal antibodies against DP. 
obtain purified HLA-DP molecules 
First, it is not easy to 
as immunogen. As was 
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suggested in the paper of Eckels et al. (1986) and the paper 
of Johnson et al. (1986), the expression of DP molecules on 
the cell membrane is a relatively low percentage of the total 
amount of class II HLA molecules expressed and is not stable. 
That is, a large number of cells is required. Moreover, the 
conventional method for purification of membrane molecules is 
painstaking and time-consuming. The application of gene 
transfection for this type of work has been a significant 
advance. However, the use of DP transfectants for producing 
hybridomas specific for HLA-DP appears to be less successful 
than was originally anticipated. Along with the reduced 
expression of DP molecules on cells, it seems that such 
molecules may be less immunogenic, for the mouse, than are 
other molecules, for example, HLA-DQ. This means that the 
frequency of specific hybridomas is low. Thus many thousands 
of hybridoma cultures must be screened in order to find any 
positives. In many experiments there may be none. 
To overcome these problems an alternative approach was 
suggested, using the technique of immunomagnetism. In this 
technique, metallic beads can be coupled to anti-DP antibodies 
and can serve as a solid phase for affinity purification of DP 
molecules. There were three attractive features to this 
technique, 1) the beads are easily manipulated with a magnet; 
2) the beads are small enough and non-toxic so that, when 
loaded with DP molecules, it seemed likely that they could be 
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injected into mice as immunogen. In this regard the work of 
Nillson et al. (1990) is relevant since they showed that 
antigens immobilized on a carrier ( 1 ike Sepharose beads, 
nitrocellulose membrane etc.) could be 
intrasplenically and induce 
reduced amount of antigen, 
an antibody response 
in the nanogram range; 
injected 
with a 
3) the 
potential existed to use these DP coated beads as a reagent 
for cell sorting, using immunomagnetisrn, to extract B cells 
whose surface immunoglobulin is specific for DP epitopes. Such 
B cell::; could in principle, be used for fusions with the 
expectation that this would result in much higher frequency of 
positive hybridomas. For these three reasons this technique 
was chosen as the subject for investigation in this study. 
5 
Chapter 2 
LITEIU\TURE REVIEW ON IMMUNOMAGHETISK 
A. HISTORY OF DEVELOPMENT OF IMMUNOMAGNETISM 
During the last decade, immunology has seen the 
introduction of an immunochemical technology in which magnetic 
fields play an important part; thus molecules, or cells in 
suspension can be manipulated by the application of magnetic 
fields following exposure to metallic beads. This recent phase 
was heralded by earlier work in which iron particles were 
used. 
The early use of magnetism in immunology dates from 
1934, in which Rous et al. first isolated hepatic 
reticuloendothelial cells (Kupffer cells) by using magnetic 
fields. In their experiment, Rous et al. (1934) injected an 
animal with carbonyl iron particles, causing Kupffer cells to 
take them up. They then killed the animal and perfused the 
liver, collecting the iron-containing cells in the perfusate 
by means of an electromagnet. This experiment was the 
beginning of the exploration of the use of magnetic fields in 
cell separation. Prompted by Rous• work, Heidelberger et al. 
(1946) studied the use of the magnetic property of "haematin 
6 
or related malarial pigments" in malaria infected red blood 
cells for concentration of malaria parasites. They took blood 
samples from patients with malaria and exposed them to a 
magnetic field, thus separating the parasite infected red 
blood cells from the normal ones with about 15 fold increase 
in concentration. A few years later, Levine (1955) fed the 
phagocytes in a blood sample carbonyl iron particles in vitro, 
then separated the phagocytes from other peripheral white 
blood cells using an electromagnet. Levine's method became a 
classical procedure to remove phagocytes from cell suspensions 
(Hudson et al. 1976). 
A remarkable development was made in the 1970's, which 
was based on the observation that the removal of reversibly 
bound oxygen from haemoglobin in red blood cells results in a 
change of the iron-haem from a non-magnetic to a paramagnetic 
state. Melville et al. (1975) treated human red blood cells 
with sodium dithionite to reduce oxyhaernoglobin to 
deoxyhaernoglobin, then separated the red blood cells from the 
whole blood by applying a strong magnetic field. owen et al. 
(1978, 1979) extended this experiment. First, they changed the 
sodium dithionite to sodium nitrite which is less damaging to 
red blood cells; then, they took nitrite-treated sheep red 
blood cells to rosette human T lymphocytes and then removed 
all the red cells as well as the rosetted T cells from the 
suspension using an electromagnet. owen et al. (1982) also 
7 
extended these experiments to allow specific separation of 
antibody secreting cellc. They used amino acid polymers as 
antigen to immunize mice. Then they coupled the antigen to 
nitrite-treated sheep red blood cells so that the red cells 
would bind to antigen-specific lymphocytes in a mouse spleen 
cell suspension. The rosetted lymphocytes were then separated 
from the rest of the spleen celJ s using a magnet. This 
experiment of Owen and his colleagues was an important step 
towards the development of targeting magnetic material to 
specific cell types. 
Later development of the magnetic separation technique 
involved the preparation of magnetic solid-phase materials to 
which enzymes or antibodies could be coupled. The advantage of 
this was that the magnetic (metallic) particles carrying the 
enzymes or antibodies could be easily manipulated, 
particularly for washing away unbound reagents. The earliest 
report of this application appears to be that of Robinson et 
al. ( 1973) . They made iron oxide-cellulose particles for 
coupling to a-chymotrypsin and ,a-galactosidase. Those 
particles were magnetised because they were made with magnetic 
iron oxide. This property meant that they tended to form 
aggregates at low stirring speeds in a reactor and could be 
removed as sediment. For full enzyme activity, deaggregation 
was easily brought about by higher stirring speeds. Thus 
enzymes could be added to, or removed from, reaction mixtures 
8 
of various types. Shortly thereafter, Hersh et al. ( 197 5) made 
silane-coated iron oxide particles for immobilizing digoxin 
antiserum. Using these antibody coupled metallic (and also 
magnetic) particles, they did a radioimmunoassay. They used a 
magnet to remove the ar~tibody coated particles an-1 in this way 
were able to separate bound from unbound antigen. Lynn Nye et 
al. (1976) repeated the last experiment but with iron oxide 
particles coated with m-diarninobenzene polymers. Metallic 
Sepharose beads (Mosbach et al. 1977) and iron-oxide treated 
starch particles (Mosbach et al. 1979) were also prepared for 
affinity chromatography and for targeting of drugs, 
respectively. 
There were two further advances in the development of 
magnetic solid phase techniques. One was made in 1977 by 
Guesdon et al. who prepared metallic polyacrylamide beads for 
use in an enzyme immunoassay. In their preparation, Guesdon et 
al. introduced active aldehyde groups (-CHO) into the beads, 
to which antibodies or other proteins could be directly 
coupled in a single step, thereby eliminating cumbersome 
intermediate procedures. Another advance was made by Molday et 
al. (1977) who first applied ? magnetic solid phase technique 
to antibody-based cell isolation. Molday et al. coupled 
metallic particles with goat anti-mouse Ig antibodies, thus 
targeting the particles to mouse B lymphocytes which express 
IgG or IgM molecules on their surface membranes. When mouse 
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spleen cells were incubated with those particles, the Ig 
expressing cells became rosetted with the metallic particles, 
thereafter, particles and B cells co~ld be separated from the 
other cells by the application of a magnetic field. The 
significance of this experiment is that due to the high 
serological specificity of the antibodies coated onto the 
metallic particles, immunomagnetic separation became a potent 
method for specific separation of defined cell types from a 
complex mixture of cells. 
Immunomagnetic separation became a widely used method 
in immunology after the development of a method for preparing 
metallic beads of uniform size. Ugelstad et al. (1983) 
developed such a procedure for making metallic beads from 
styrene divinylbenzene. Using this methodr the metallic beads 
were nearly identical in size, density and iron oxide content. 
Each bead comprised an iron core and a polymer shell. 
Functional groups could thus be incorporated into the surface 
of the beads, which could be modified for physical absorption 
or coval' · nt coupling of antibodies or other proteins. The 
newly developed metallic beads quite soon became commercially 
available, which allowed their widespread use. 
10 
B. THE APPLICATION OF METALLIC BEADS 
B.l. Removal of tumour cells from bone marrow 
A large dose of chemotherapy and/or radiotherapy is 
often required for treatment of malignant diseases. Compared 
with other tissues, bone marrow is more vulnerable to drug and 
radiation therapy. One option to overcome this problem is to 
collect a portion of bone marrow before high dose cytotoxic 
therapy is given. It is then reinfused to rescue the 
haemopoietic system after the treatment (autologous bone 
marrow transplantation). However, in cases with metastatic 
tumours, malignant cells would be harvested together with the 
normal bone marrow cells. Reinfusion of such cell suspensions 
could lead to reseeding of tumour cells along with the normal 
progenitor cells. Metallic beads have provided a useful tool 
for depleting tumour cells from such bone marrow samples. 
Poynton et al. ( 1983) first reported the application of 
immunomagnetic separation to remove leukaemic cells from a 
patient's bone marrow in the treatment of a child with common 
acute lymphocytic leukaemia (cALL) • They harvested bone marrow 
from the child with cALL and incubated the bone marrow cells 
with metallic beads coated with monoclonal antibodies against 
the cALLA surface antigen (now COlO) of leukaemic cells. The 
11 
tumour cells were then separated from the normal ones using a 
magnetic field. After the high dose cytotoxic drug therapy, 
the tumour cell depleted bone marrow cells were reinfused to 
restore the normal bone marrow function. The marrow was 
evidently repopulated quite soon, but long term outcome was 
not reported. 
Metallic beads were used by Treleaven eta~. (1984) for 
removal of neuroblastoma cells from bone marrow in the 
treatment of patients with metastatic neuroblastoma. In order 
to maximi~e tumour-cell depletion, a panel of six different 
mouse IgG anti-neuroblastoma antibodies was used first to 
sensitize target cells, which, thereafter, were removed by 
adding metallic beads coated with anti-mouse Ig, followed by 
magnetic separation. Again the re-engraftment after 
chemotherapy was successful, but long term outcome was not 
reported. 
Numerous similar approaches have since been described. 
In recent yaars, immunomagnetic purging of breast cancer cells 
and lung carcinoma cells from the bone marrow of the patients 
with advanced malignant diseases has been studied (Anderson et 
al. 1989; Vredenburgh et al. 1990, 1991). Although no 
randomized clinical trial has so far been conducted comparing 
autologous bone marrow transplantation with and without in 
vitro marrow purging, the use of this procedure has been 
regarded by some laboratories as a routine part of the 
12 
treatment for patients undergoing autologous bone marrow 
transplantation (Pole et al. 1990). 
B.2. Depletion of T lymphocytes from bone marrow 
Allogeneic bone marrow transplantation has been the 
treatment of choice for aplastic anemia, leukaemia and other 
disorders of haematopoietic system (0 'Reilly 1983). One of the 
major obstacles to the success of allogeneic bone marrow 
transplantation is graft versus host disease (GVHD) which is 
initiated by immunocompetent donor T lymphocytes responding to 
alloantigens expressed on host cells. In attempts to avoid 
this complication by depletion of T lymphocytes from the 
marrow inoculum, the immunomagnetic separation method was 
examined. In 1987, Vartdal et al. reported using metallic 
beads coated with monoclonal antibodies specific for T cell 
C02 and CD3 antigens to remove T lymphocytes from human bone 
marrow cell suspensions. Shortly after that, several similar 
reports were published (Geisler et al. 1989 ~ Frame et al. 
1989 ~ Gee et al. 1989) . However, it is not yet clear if 
imrnunomagnetism has real advantages for purging T cells, when 
compared with other methods, such as antibody plus complement 
or antibody coupled to a cytotoxic molecule. 
B.3. Positive and negative cell selection for functional 
assays 
13 
There have been many reports about the use of metallic 
beads for cell selection. The use of metallic beads for 
positive cell selection can be illustrated by the earlier work 
of Gaudernack et al. (19S6) and Sollid et al. (19S6) who 
isolated cos+ T lymphocytes from peripheral blood by resetting 
cells with metallic beads coated with antibody against CDS 
membrane molecules. With these purified cells they studied the 
functional properties of coa+ T cells in response to 
allogeneic cells and soluble antigens. In their experiments, 
the presence of metallic beads appeared not to interfere with 
the effector function of the selected T lymphocytes. 
Another example of the application of metallic beads to 
positive cell selection is the study of lymphocytes isolated 
from synovial fluid of patients with arthritis (HoVdP.nes et 
al. 1989a, 1989b and 1989c). In this study, metallic beads 
were coated with antibodies against CD4 or CDS molecules and 
were mixed with synovial fluids from patients with rheumatoid 
arthritis and other types of arthritis. CD4+ or CDS ... T 
lymphocytes were isolated from the synovial fluid as they 
ros~tted with the beads and were compared with the normal T 
lymphocytes from heal thy peripheral blood with respect to 
their ability to proliferate in response to mitogens, produce 
interleukin 2 and gamma interferon and to express activation 
14 
markers. 
It has been found that metallic beads bound to cells 
during selection can be detached by incubating rosettes at 37° 
I 
C for 16-20 hours (Lea et al. 1986; ~underud et al. 1990). 
However, th~ detachment of beads only occurred in certain 
cells. Nilsson et al. ( 198 7) has reported in a study with 
Langerhans' cells that metallic beads could not be detached 
from cells even if the rosettes were cultured for 24 hours and 
pipetted vigorously. It was assumed that the easy detachment 
of beads from B cells is due to relatively frequent antigen 
shedding on B cell membranes (Funderud et al. 1990). 
Recently, Rasmussen et al. (1992) h~ve described a new method 
for detachment of metallic beads from positively selected B 
lymphocytes. In this method, anti-Fab antibody was used to 
separate the bond between the anti-mouse Ig antibody on 
metallic beads and the surface Ig of B lymphocytes: whether 
this is due to the competitive binding mechanism or the result 
of a conformation change, which affects the antigen binding 
site, cannot be stated at present. 
An example of the application of negative cell 
selection using metallic beads is a study on the role of 
untigen presenting cells (Tjernlund et al. 1988) . In this 
study, Tjernlund and his colleagues removed Langerhans' cells 
from epidermal cell suspensions using metallic beads coupled 
with anti-COl antibodies. Then they examined T-cell response 
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to purified protein derivative (PPD) in these suspensions. 
This exp~riment gave strong evidence that keratinocytes do not 
take part in antigen presentation even though they are found 
to be HLA-DR-expressing under certain conditions. 
B.4. Tissue typing 
The application of immunomagnetic techniques to 
serologic tissue typing has been described in several reports. 
These reports describe two ways to make use of metallic beads 
for phenotyping lymphocytes. In the first, the cells to be 
typed are isolated from peripheral blood by positive cell 
selection using metallic beads coupled with antibody specific 
for a defined cell type. Then, without removal of the beads, 
they are made to react with typing sera and complement. The 
results are read in a fluorescence microscope employing a 
mixture of ethidium bromide and acridine orange to monitor the 
viability of the cells (Vartdal et al. 1986, 1987; Povlsen et 
al. 1988) . This method was compared with the conventional 
Kissmeyer-Nielsen technique (Vartdc:.l et al. 1986; Povlsen et 
al. 1988, 1991). It w~s shown that the phenotyping assay with 
the use of jmmunomagnetic technique had advantages over the 
conventional one. First, the donor's cells could be obtained 
quickly with good purity and viability. This time-saving 
16 
procedure was preferred for phenotyping cadaveric donors as it 
helps to prevent a prolonged cold ischemia time. Second, as 
purified cells of the specific type were used in the assay, 
the sensitivity was increased, particularly in HLA class II 
typing. 
Another way of using metallic beads for tissue typing 
is based on identification of cells that have formed rosettes 
with metallic beads conjugated with monoclonal antibodies 
directed against cell-surface antigens. In a study by Hansen 
et al. { 1987) , monoclonal antibodies specific for HLA-827 were 
coupled to metallic beads. When these beads were mixed with a 
small amount of whole blood, they formed rosettes with HLA-
B27-bearing leucocytes. Removal of red cells and other debris 
by washing in either lysis buffer or PBS was achieved with the 
aid of a magnet, to immobilize the beads while the supernatant 
fluid was "flicked" off. This method allowed typing for HLA-
B27 to be accomplished in about 20 min by microscopic 
evaluation of rosette formation. In another study of 
Skjonsberg et al. {1990), monoclonal antibodies against 
antigens on myeloma or lymphoid cells were coupled to metallic 
beads. Phenotyping of acute leukaemias was then performed. 
Comparison of the rosette assay with conventional 
microcytotoxicity assays showed in both studies that with the 
use of metallic beads the sensitivity was increased. 
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B.S. Antigen-specific cell selection 
An interesting use of inununomagnetic separation in 
immunology is the enrichment of specific antibody secreting 
cells using antigen-coupled metallic beads. There are two 
examples of such an application. One is the experiment of 
Egeland et al. (1988) who coupled metallic beads with rabbit 
IgG and used these beads to rosette rheumatoid factor positive 
B lymphocytes from peripheral blood of patients with 
rheumatoid arthritis. This method is based on the fact that 
the Fe fragment of rabbit IgG is specifically recognized by 
rheumatoid factors of IgG, IgM and IgA isotypes. The rosetted 
RF secreting B cells were collected using a magnet and were 
transformed with Epstein-Barr virus for bulk expansion. 
Unfractionated B cells from RA patients were also transformed 
as controls. The frequency comparison in this experiment 
showed that 103- to 104-fold enrichment of antigen-specific B 
lymphocytes was obtained using these antigen coupled beads. 
Another example of such application is the work of 
Ossendorp et al. ( 1989) , in which antigen coupled metallic 
beads were used for selection of high affinity B cell 
hybridomas. In an attempt to obtain high affinity 
thyroglobulin-specific antibody secreting hybridomas, 
Ossendorp and his colleagues coupled thyroglobulin to metallic 
beads and incubated them with bulk cultures of hybridoma 
cells, obtained by fusing immune spleen cells from 
lB 
thyroglobulin immunized mice with myel~ma fusion partner 
cells. The rosetted hybridoma cells were isolated from the 
unrosetted cells and subsequently cultured and tested. It was 
shown :_n their experiment that a 300-fold enrichment of 
thyroglobulin-specific hybrid cells was obtained using this 
method. These two experiments provided a possible 
circumvention of the problem associated with low frequency of 
specific antibody secreting hybrids in attempts to create 
specific hybridomas. 
This literature search did not find any reports of the 
use of immunomagnetism for biochemical purification of 
molecules, nor for the pre-fusion selection of antigen-
specific B cells for making hybridornas. Both of these were 
explored in this thesis. 
Chapter 3 
OBJECTIVES 
19 
The objective of this thesis was to explore the 
possibility of using techniques of immunomagnetism to replace 
certain cumbersome procedures in monoclonal antibody 
production, specifically (1) a simple method was sought to 
purify HLA-DP molecules from cell lysate and (2) it was hoped 
to improve the yield of fusions using HLA-DP immunized mice, 
by pre-fusion enrichment for putative antigen-specific cells. 
This overall objective can be broken down into 3 parts. 
1. To couple anti-DP antibody to metallic beads and to use 
them to extract HLA-DP molecules from cell lysates. 
2. To evoke antibody responses in mice by immunizing them with 
metallic beads absorbed with HLA-DP molecules. 
3. To enrich IgG-bearing or antigen-specific B lym~hocytes 
from mouse spleen cell suspensions using anti-IgG or antigen 
coupled metallic beads, respectively, and to fuse the selected 
cells with myeloma cells by application of the centrifugal 
electrofusion technique. 
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Chapter 4 
MATERIALS AND METHODS 
A. CAPTURE OF DP MOLECULES ONTO METALLIC BEADS 
A.1. Determination of the optimal concentration of anti-DP 
antibodies for binding transfectant cells 
Materials 
NFLD.M58: A monoclonal antibody specific for an HLA-DP 
polymorphism which includes DPB1*0201, DPB1*0301, DPB1*0402, 
DPB1*0901 and DPB1*1001 (Drover et al. 1991). 
NFLD.M67: A monoclonal antibody specific for a monomorphic 
determinant on HLA-DP (Marshall et al. unpublished). 
(Both antibodies are used as hybridoma culture supernatants 
from the Immunology laboratory of Memorial University of 
Newfoundland) 
Secondary antibody: Affinity purified F(ab') 2 fragments of 
goat anti-mouse IgG + IgM, conjugated with fluorescein 
isothiocyanate ( FITC) (Jackson Irnmunoresearch laboratories, 
West Grove, PA) . 
Culture and washing medium: Dulbecco's modification of 
Eagle's medium (DMEM) supplemented with 10% fetal calf serum 
(FCS) , 2mM L-glutamine, 5x10-5M 2-mercaptoethanol, soouni tsjrnl 
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penicillin, 5001-'g/ml streptomycin and 0. 25mg/ml geneticin 
(G418 sulphate) (DMEM, FCS, L-glutamine, penicillin and 
streptomycin were all from GIBCO Laboratories, Grand Island; 
2-mercaptoethanol was from Sigma Chemical co., StLouis, MO). 
L25.4 transfectant cells: These are HLA-DP-expressing L-cell 
transfectant cells containing DPA1*0101 and DPB1*0402 genes 
(Lair et al. 1988; Klohe et al. 1988). The cells were grown in 
culture medium at 37°C in 10% co2 atmosphere at a density of 
2xl06jdish, and harvested 48 hours after being treated with 
trypsin. 
Method 
1). Monoclonal antibodies M58 andjor M67 in concentrated, 
untreated or serially diluted solutions were prepared. 
2). 2x105 L25.4 transfectant cells were prepared in each of 
ten tubes. 
3). The cells were washed twice with ice cold washing medium 
by spinning at 200xg for 5min. 
4). The cells were incubated with appropriate dilutions of 
M58 or M67 (1001.'1) at 4°C for 30min. 
5). The cells were washed three times with ice cold washing 
medium. All supernatant was removed. 
6). The cells were incubated with the secondary antibody 
(1001.'1) at 4°C for 30rnin. 
7). The cells were washed three times as before. 
0). The cells were resuspended in lml of washing medium; 
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they were then ready for flow cytometric analysis. 
A.2. Cross Blocking of I3 by M58 or M67 
Materials 
I3 is a monoclonal antibody specific for a monomorphic 
determinant on MHC class II molecules; it is conjugated with 
FITC (Coulter Immunology, Hialeah, FL). Flow cytometric 
analysis of the antigen specificity of !3 using transfectant 
cells as targets showed the following results: 
L25.4 DP8303 DP8306 DQ8205 DR8131 DR8137 DR8114 
(DPB1*0402) (0PB1*0401) (DPB1*0901) (DQB1*020t) (DRB1*1001) (DRB4*0101) (DRB1*04 •• ) 
IJ + + + + 
This data suggests but does not prove that it is largely 
specific for HLA-DP with very little binding to DQ or DR 
molecules. 
NFLD.M58: See above 
NFLD.M67: See above 
L25.4 transfectant cells: See above 
Washing medium: See above 
Method 
L25. 4 transfectant cells {2xl05 ) were washed twice with 
ice cold washing medium at 200xg for 5min. They were then 
inGubated with M58 or M67 (100~1) at 4°C for one hour. The 
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cells were washed three times again and incubated with IJ 
(10~1) at 4°C for half an hour. After three washes to remove 
free I3, The cells were resuspended in lml of washing medium 
and analyzed by flow cytometre. 
A.3. Coating metallic beads with anti-DP antibody 
Materials 
Metallic beads: Covalently coupled with goat anti-mouse IgG 
{Dynal Inc., Great Neck, NY) 
Anti-DP antibody: M67 andjor M58 (see above) 
Washing solution: Phosphate buffered saline, pH7.4, 
containing 1% fetal calf serum (PBS/FCS). 
Magnetic particle concentrator (Dynal Inc., Great Neck, NY) 
M€:1thod 
The metallic beads were suspended by lightly shaking 
the bottle. The desired amount of beads (4xl08/ml) were drawn 
into a syringe and transferred to a 15ml centrifuge tube. The 
beads were washed twice with PBS/FCS by attaching the tube to 
a magnetic particle concentrator for one minute, followed by 
pouring off the supernatant. After washing, the metallic beads 
were resuspended in M67 or M58 monoclonal antibody solution 
and then were incubated on a rotator at 4°C overnight. The 
following day, the metallic beads with M58 or M67 antibodies 
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attached were washed four times as before so that the free 
antibody molecules were removed. 
A.4. Preparation of cell lysates 
Materials 
Human B cell lines: H030l{DPB1*0501), COX{DPB1*0301), 
SAVC{DPB1*1001) and WT51(DPB1*0201) (S. Y. Yang et al. 1989) 
Transfectant cells: DP8303 and DP8306 bearing 
DPB1*0401/DPA1*0101 and DPB1*0901/DPA1*0201 respectively (Lair 
et al. 1988; Klohe et al. 1988) 
B cell line culture medium: RPMI-1640 supplemented with 10% 
fetal calf serum, 2mM L-glutamine, 1% sodium pyruvate, 
soounitsjml penicillin and soo~g/ml streptomycin 
Transfectant cell culture medium: DMEM supplemented with 10% 
fetal calf serum, 2mM L-glutarnine, 5x10.5M 2-mercaptoethanol, 
soounitsjml penicillin, soo~g/ml streptomycin and 0.25mg/ml 
geneticin (G418 sulphate) (for DP8306 cells) or 1% 
hypoxanthine/methotrexate/thymidine {HMT) (for DP8303 cells) 
Lysing buffer: 0.15M NaCl, O.OlM Tri-HCl, pH8.2, lrnM EDTA, 
2mM phenylmethylsulfonyl fluoride, 0.5% Nonidet P-40, lmgjml 
bovine serum albumin (Sigma Chemical Co., St. Louis, MO, USA) 
Note: RPMI, DMEM, L-glutamine, penicillin, streptomycin and 
fetal calf serum were all from GIBCO, Grand island, NY; 2-
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mercaptoethanol was from Sigma Chemical co., st. Louis, MO. 
Method 
Cell lysates were prepared as previously described by 
Schneider et al. (1982) and Goding (1986). Human B cell lines 
were grown in the B cell line culture medium at 37°C in 5% co2 
atmosphere at a density of 2x105jml; transfectant cells were 
grown in transfectant cell culture medium at 37°C in 10% C02 
atmosphere at a density of 5xl06jdish. To prepare cell 
lysates, the cells were washed twice with ice cold cell 
culture medium at 200xg for 5min, and then resuspended in ice 
cold lysing buffer. For each 1x108 cells , 1-2ml lysing buffer 
was added. After incubating at 4°C for 20min, the lysate was 
centrifuged for JOmin at 3000xg, 4°C to sediment nuclei and 
debris. The supernatant was decanted and ready for use. 
A.5. Absorption of DP molecules from cell lysates 
After being coated with anti-DP antibody, metallic 
beads developed affinity for DP molecules and acted as a solid 
phase for immune absorption of DP molecules. The absorption 
was performed by mixing the metallic beads with the cell 
lysate and incubating the mixture on a rotator at 4°C 
overnight. The following day, the metallic beads were 
collected and washed once with ice cold lysing buffer and 
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twice with cold PBS/FCS, using a magnetic particle 
concentrator to retain the beads while the supernatant fluid 
was poured off and discarded. After the last wash the beads 
were resuspended in PBS/FCS. 
A.6. Staining DP-absorbed beads with I3 antibody 
After the above absorption the metallic beads were 
first incubated with normal mouse serum at 4°C for 30min to 
block nonspecific binding sites. Then, the mouse serum was 
removed using a magnet to retain the beads, and the beads 
were incubated with 10~1 of I3 for another 30min at 4°C. After 
that, they were washed three times with ice cold PBS/FCS and 
resuspended in lml of the same buffer for flow cytornetric 
analysis. 
A.7. Specific blocking of I3 by M58 binding to DP-absorbed 
beads 
Materials 
IJ: See above 
NFLO.M58: A monoclonal antibody specific for a DP 
polymorphism (see above) 
Metallic beads with absorbed molecules derived from a cell 
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lysate made from WT51 B cell line cells (DPB1*0201/DPA1*0101). 
Washing buffer: PBS/FCS (see above) 
Method 
After absorption of DP molecules from a cell lysate and 
blocking nonspecific staining using normal mouse serum (see 
Method above), one million metallic beads were incubated with 
M58 (200~1) at 4°C for 30min with intermittent stirring. After 
that, the M58 supernatant were removed using a magnet, and the 
fluorescent antibody !3 was added. Another incubation was then 
done under the same conditions. This was followed by three 
washings with PBS/FCS using a magnet and the beads were 
resuspended in lml of the same buffer for flow cytometric 
analysis. 
A.C. staining DP-absorbed beads with biotinylated M67 
Materials 
Biotin-M67: Monoclonal antibody against a DP monomorphism 
(see above) conjugated with biotin, 1/10 diluted (I~munology 
laboratory, Memorial University of Newfoundland). 
Avidin-FITC: 1/100 dilution (Calbiochem, La Jolla, CA 92037). 
M58 coated onto metallic beads: See above 
Cell lysate: Made from WT51 B cell line cells (see above) 
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Method 
Immune absorption of DP molecules from a cell lysate 
using M58 coated metallic beads was performed as described 
above. Then, the beads were blocked with normal mouse serum by 
incubating them at 4°C for 30min. After that, 100~1 biotin-M67 
was added to the beads and another incubation was done under 
the same conditions. After three washings with PBS/FBS, the 
metallic beads were stained with 100~1 avidin-FITC by 
incubating them at 4°C, 30min. Finally, the metallic beads 
were washed three times with PBS/FBS and resuspended in lml of 
the same solution for flow cytometric analysis. 
B. IMMUNIZATION METHODS 
B.l. Primary immunization 
Materials 
Immunogen: DP-absorbed metallic beads in sterile PBS 
Adjuvant: Complete Freund's adjuvant 
Mice: Balb/c and C3H mice aged from 2-6 months. 
Method 
One volume of metallic beads was emulsified with two 
volumes of complete Freund's adjuvant using two syringes 
connected via a double ended fitting. 300~1 of the emulsion 
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was then injected into each mouse subcutaneously at 2 or 3 
sites on the back. 
8.2. Secondary immunization 
Materials 
Immunogen: OF-absorbed metallic beads suspended in sterile 
PBS 
Adjuvant: Incomplete Freund's adjuvant 
Mice: Same as in the primary immunization 
Method 
The secondary immunization was done four weeks after 
the primary immunization. One volume of metallic beads was 
emulsified with two volumes uf incomplete Freund's adjuvant. 
300~1 of the emulsion was then injected into each mouse 
intraperitoneally. 
8.3. Antigen boost before splenectomy and fusion 
Materials 
Immunogen: OF-absorbed metallic beads; or the cells used for 
preparation of cell lysates. 
Sterile PBS 
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Method 
The boost was done two days before fusion. sx107 beads 
absorbed with DP molecules were suspended in 100~1 of PBS, 
then they were injected intrasplenically; or 2x107 cells were 
suspended in 100~1 of PBS, then they were injected 
intravenously via the tail vein. 
B.4. Collection of immune mouse serum 
The mouse were lightly warmed in a procedure room by 
raising the room temperature to about 26-28°C. The last 2-Jmm 
of the tail was then chopped off with a clean scalpel blade. 
Several drops of blood were collected in this way into a 
microcentrifuge tube which is left at 4°C overnight to allow 
the clot to retract. The following day, the serum was 
recovered after centrifugation to sediment the red cells and 
clot. The serum was transferred to an Eppendorf tube and was 
stored frozen until ready for use. 
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C. ANTIBODY MEASUREMENT BY CELISA 
C.l. Assay of specific antibody using B cell line cells as 
antigen 
Materials 
Antigen (Target): Human B cell line cells HOJOl, COX, SAVC 
and WT51 (these were the ones used for immunizations) . 
First antibody: Mouse serum or hybridoma supernatant under 
test 
Second antibody: Affinity purified F(ab')z fragments of goat 
anti-mouse IgG and IgM conjugated with horse radish peroxidase 
(Jackson Immunoresear~h Laboratories, West Grove, PA), 1/2500 
in PBS containing 2% bovine serum albumin. 
Washing buffer: Phosphate buffered saline containing o. 5% 
bovine serum albumin (Sigma Chemical Co, st Louis, MO) 
Pol)r-L-Lysine (PLL) ( lmgjlOOml): 1 Omg PLL ( Hydrobromide, 
molecular weight 180,000, from Sigma Chemical Co.) in lOOOml 
PBS, stored at 4°C. 
Phosphate citrate buffer, pHS.O: 
A. O.lM citric acid solution: 1.92g citric acid in lOOml 
distilled water 
B. 0.2M phosphate solution: 2.82g phosphate in lOOml 
distilled water 
Mix 4.9ml citric acid solution with S.lml phosphate solution 
32 
and lOrnl of distilled water. 
Substrate: 4mg of orthophenylenediarnine (OPD) dissolved in 
lOml phosphate citrate buffer. When OPD is completely 
dissolved, 4~1 of 30% H2o2 is added. 
2. 5N H2S04 
Plates: 96-well U-bottorn polyvinyl chloride microtitration 
plates (PVC) and 96-well Enzyme-Immunoassay microplates 
Method 
1). Target cells were washed one time with washing buffer 
at 200xg for lOmin and plated on PVC plates at 
"lx104/10~1/well. 
2). 25J..Ll of diluted mouse serum or hybridoma supernatant was 
added to each well and incubate with the cells at room 
temperature for one hour. 
3). The cells were washed 3 times by adding 125~1 washing 
buffer to each well, spinning at 150xg for 5rnin at 8°C 
and flicking off supernatant. 
4). The second antibody was added with 50~1 per well and 
incubated at room temperature for one hour. 
5). In the mean time, EIA plates were coated with 75J..Ll PLL 
per well. After 30min, the plates were drained by 
flicking off supernatant. 
6). The cells were washed four times as before. 
7). The U-bottom PVC plates were fitted onto the EIA plates. 
100~1 washing buffer was added to each well, a hole was 
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punched in the centre of each well using an 18 gauge 
needle. 
8). The plates were spun at 150xg for 7rnin, then the PVC 
plates were removed and the supernatant was flicked 
off. 
9). Substrate was added, 100~1/well; the plates were left 
in the dark for JOmin. 
10). 50~1 H2S04 was added to each well to stop the colour 
development. 
11). The plates were read in Multiscan Spectrophotometer at 
490nm wavelength. 
C.2. Assay of specific antibody using transfectant cells as 
targets 
Materials 
Target cells: Transfectant cells DP8303 and DP8306 (see 
above) 
First antibody: mouse serum or hybridoma supernatants under 
test 
Second antibody: Affinity purified F(ab')2 fragments of goat 
anti-mouse IgG and IgM conjugated with horse-radish peroxidase 
(Jackson Immunoresearch Laboratories, West Grove, PA), 1/2500 
diluted in PBS containing 2% bovine serum albumin. 
Washing buffer: Phosphate buffered saline containing 0.05% 
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Tween-20 detergent 
Phosphate citrate buffer, pHS. 0: See "Assay using B cell line 
cells as target". 
Substrate: See "Assay using B cell line cells as target11 • 
2. SN H 2S04 
Plate: 96-well tissue culture plate 
Method 
1). Transfectant cells were plated in tissue culture plates, 
sx104 cells in 100~1 DMEM culture medium(see above) per 
well~ and incubated at 37°C overnight. 
2). The cells were washed one time by adding 150~1 washing 
buffer to each well and then flicking it off. 
3). 25~1 diluted mouse serum or hybridoma supernatant was 
added to each well, and incubated at room temperature 
for one hour. 
4). The cells were washed four times as before. 
5) . The second antibody, 50~1 per well, was added and 
incubated at room temperature for one hour. 
6). The cells were washed four times as before. 
7). Substrate, 100~1 per well, was added and the plates were 
left in the dark for 30min. 
8). 50~1 H2S04 was added to each well to stop the colour 
development. 
9) • Optical density was measured in Multiscan 
Spectrophotometer ~t 490nm wavelength. 
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D. CELL SELECTION AND HYBRIDOMA METHODS 
D.l. Growing myeloma cells 
Materials 
Cell culture medium: DMEM supplemented with 10% fetal calf 
serum, 2rnM L-glutamine, 500unitsjml penicillin, 
streptomycin, 5xl0-5M 2-mercaptoethanol (DMEM, 
SOO~gjml 
FCS, L-
glutamine, penicillin and streptomycin were all from GIBCO, 
Grand Island, NY; 2-mercaptoethanol was from Sigma Chemical 
Co., StLouis, MO) 
Tissue culture flask 
Method 
SP2jo myeloma cells were grown in culture medium at 
37°C in a 5% C02 atmosphere. Before fusion, the cells were kept 
growing at a density of 5xl04 to 1x105 cells per rnl. with a 
viability of 95%, for two to six weeks. 
0.2. Obtaining the mouse spleen cells 
The immunized mouse was killed with Ethrane followed by 
cervical dislocation, and was then sterilized by immersion in 
70% ethanol. The mouse abdominal skin was incised 
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longitudinally and separated from the abdominal wall. Then, 
the abdominal cavity was opened and the spleen was dissected 
and removed to a petri dish containing 5ml cold DMEM. After 
trimming the fat away, the spleen was transferred to another 
dish with 5ml cold medium. The spleen cells were then squeezed 
out of the organ after making a small cut at both poles, 
gently massaging the spleen with two bent syringe needles 
mounted on syringes. When most of the spleen cells were 
squeezed out in this way, they were transferred to a 15ml 
centrifuge tube on ice. The cells are pipetted several times 
and allowed to stand for a while to let large aggregates 
settle out. The cell suspension was then transferred to 
another centrifuge tube and washed three times with cold 
medium at 200xg for 5min. After the final wash the cells were 
counted. 
0.3. Selection of IgG-bearing B cells 
Materials 
Metallic beads covalently coupled with goat anti-mouse IgG 
(all subclasses) (Dynal Inc., Great Neck, NY) 
Magnetic particle concentrator (Dynal Inc., Great Neck, NY} 
Spleen cell suspension from an immunized mouse. 
Cell culture medium: DMEM supplemented with 10% fetal calf 
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serum, 2mM L-glutarnine, 500unitsjml penicillin, 500~gjml 
streptomycin, 5xl0"5M 2-mercaptoethanol (DMEM, FCS, L-
glutamine, penicillin and streptomycin were all from GIBCO, 
Grand Island, NY; 2-rnercaptoethanol was from Sigma Chemical 
co., st Louis, MO) 
PBS containing 1% FCS 
Method 
The metallic beads were washed three times with PBS/PCS 
to remove cytotoxic preservative. Then they were mixed with 
spleen cells in 5ml ice cold culture medium. The mixture was 
incubated on a rotator at 4°C for one hour. After that the 
metallic beads and the cells bound to them were separated by 
attaching the tube to a magnet; while the beads were held on 
the wall, the supernatant and free cells were poured off. The 
bead-selected cells were then resuspended in lOml medium and 
counted. 
D.4. Selection of antigen-specific B lymphocytes 
Materials 
Metallic beads that had absorbed DP molecules from a WT51 B 
cell line cell lysate (DPB1*0201) 
Spleen cell suspension from a Balb/c mouse immunized with DP 
molecules from WT51 B cells. 
Cell culture medium: see above 
PBS containing 1% FCS 
Met: hod 
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DP absorbed metallic beads were washed three times with 
PBS/FCS, then mixed with spleen cells. The mixture was 
incubated on a rotator at 4°C for one hour. After that the 
metallic beads and the cells bound to beads were separated 
from free cells as described before. The selected cells were 
resuspended in lOml cell culture medium and then counted. 
0.5. Centrifugal-Electrofusion of bead-selected cells 
Mat:erials 
Fusion buffer: It is a low ionic strength sucrose-phosphate 
buffer made up as follows: First, mix 21.6ml of 1/15M KH2Po4 
solution with 54. 2ml of 1/15M Na2HP04 solution, adjust pH value 
to 7. 2 and add distilled water to 500ml; then add 42. Sg 
sucrose and O.l017g MgC12 .6H2o to the final solution. 
centrifugal electrofusion facility (Designed and constructed 
in Memorial University of Newfoundland) : The electrical 
pulsing circuit has been described by McCormick et al. (1992). 
For these experiments it was connected to specially designed 
centrifuge tubes that have built- in electrodes. The apparatus 
was made in such a way that cells, sedimented into a pellet in 
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the centrifuge tube, could be exposed to brief high voltage 
pulses whilst the centrifuge was rotating. 
Cell culture medium: DMEM supplemented with 20% FCS 
Method 
The bead-selected cells without detachment of beads 
were mixed with SP2/o myeloma cells in a ratio of 5:1 and were 
washed once with fusion buffer. Then they were resuspended in 
fusion buffer at a total cell concentration of 1-7xlO~ml. 
200~1 of the cell suspension was placed into a fusion chamber. 
The chamber was then spun in the centrifuge at 120xg for 3-
4min to allow the cells to form a pellet. While the centrifuge 
continued to rotate, two consecutive electrical field pulses 
were delivered to the cells. After pulsing, the centrifugation 
was maintained for a further 5 minutes. Then the pulsed cells 
were transferred to cell culture medium. Finally the pulsed 
cells were plated in 96-well culture plates with 1.5xlo5 cells 
in 100~1 culture medium being placed in each well. 
0.6. Growing hybridoma cells 
The fused cells were plated in 96-well flat-bottomed 
plates~ mouse red blood cells were added as feeders (2xl06 per 
well). About 48 hours later, 100~1 cell culture medium 
supplemented with HAT (hypoxanthine, aminopterin and 
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thymidine) were added to each well. The cells were then fed 
every two days with the same medium. When all SP2/o cells in 
control wells were dead, the cell culture medium was changed 
to a medium with supplemental HT (hypoxanthine and 
thymidine) . About 8-12 days later when sufficiently grown, the 
culture supernatants were screened for specific antibody by 
CELISA (see above). 
0.7. Collection of hybridorna supernatant 
About ten days after fusion, 25~1 of supernatant from 
each well with hybridoma growth was taken and tested against 
the immunogen cells using the CELISA assay described above. 
The positive hybridomas were transferred to 24-well plates for 
expansion. After further testing, cultures with interesting 
specificities could be either cloned, or the cells frozen 
pending more rigorous testing. 
Chapter 5 
RESULTS 
A. IMMUNE ABSORPTION OF DP MOLECULES 
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The purpose of these experiments was to devise a method 
for extracting HLA-DP molecules from cell lysates. The concept 
was to use a monoclonal antibody against an HLA-DP monomorphic 
determinant as a capture antibody, and to have it bound to 
metallic beads. Since such beads can be manipulated with ease 
with the help of a magnet, this would make the whole procedure 
quite rapid. 
A.l. Choice of antibodies for coating metallic beads 
At the time that this work was begun, there were two 
monoclonal antibodies available locally. One was NFLD.M58 that 
binds to DP polymorphic epitopes; the other one was NFLD.M67 
that appeared to be specific for HLA-DP monomorphic 
determinants. The problem was to choose one of them as a 
capture antibody, which would not block the fluorescent 
antibody, !3, that we had selected for detection of DP 
molecules by immunofluorescence. 
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a. The optimal concentration of anti-DP antibodies for 
binding cells 
Before testing to see if M58 and/or M67 block the 
binding of !3 to HLA-DP determinants, the optimal 
concentrations of M58 and M67 needed to coat a given number of 
transfectants had to be determined. Various concentrations of 
M58 and M67 were tested for their reaction with a certain 
number of DP transfectant cells. The cells were first 
incubated with anti-DP antibody, then with secondary antibody 
conjugated with FITC. The antigen-antibody reaction between DP 
transfectants and M58 or M67 was estimated by quantifying 
fluorescence using flow cytometry. The results of M58 are 
shown in Figure 1; the results of M67 in Figure 2. In both 
figures, fluorescence increased as the dilution of antibody 
decreased, up to and including the original, undiluted 
supernatant. Beyond this, concentrating the original 
supernatant is seen to have little effect on the fluorescence 
intensity. This suggests that the original or slightly 
concentrated supernatant contains antibody around a 
concentration which causes maximum reaction between M58 or M67 
and DP transfectant cells. Therefore the original (undiluted 
and unconcentrated) or concentrated supernatant was chosen for 
cross blocking tests. 
Note: Because of the design of the concentrator, it ie difficult to obtain 
identical concentrations each time the concentrator ia ueed. 
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Figure 1. Determination of the optimal concentration of M58 
Various concentrations of M58 were reacted with a standard 
number of L25.4 transfectant cells (2xl05). The reaction was 
identified by a second antibody labelled with FITC and was 
quantified by flow cytornetric analysis of fluorescence. A. 
Panel a shows the negative control in which the cells had not 
been exposed to the FITC-labelled antibody. In panels b-d, 
concentrated M58 supernatants were used; in panel e, original 
M58 hybridorna supernatant was used; in panels f-j, M58 was 
serially diluted. B. The fluorescence intensity* increased as 
the concentration of M58 increased. Beyond the concentration 
of 2.5x, the increase in fluorescence intensity became less. 
* Fluorescence intensity refers to the mean intensity. 
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Figure 2. Determination of the optimal concentration of M67 
Various concentrations of M67 were reacted with a standard 
number of L25.4 transfectant cells (2xl05). The reaction was 
identified by a second antibody labelled with FITC and was 
quantified by flow cytornetric analysis of fluorescence. A. 
Panel a shows the negative control in which the cells had not 
been exposed to the FITC-labelled antibody. In panels b-d, 
different concentrations of original M67 supernatant were 
used; in panel e, original M67 hybridoma supernatant was used; 
in panels g-j, M67 was serially diluted. B. The increase in 
fluorescence intensity* became less 
concentration continued increasing. 
apparent as 
* Fluorescence intensity refers to the mean intensity. 
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b. Cross blocking I3 by M58 or M67 
An experiment for testing M58 and M67 was performed to 
see if those antibodies would block I3 binding to DP 
transfectants. The cells were first incubated with M58 or M67, 
then with I3. After that, the cells were examined for 
fluorescence using flow cytometry. The results are shown in 
Figure 3 , in which we can see that, after incubation with 
M67, the DP transfectants could still be stained by I3, and 
the fluorescence did not change, as comparing histogram d with 
b and c; while after incubation with M58, the transfectants 
showed greatly reduced fluorescence, as comparing histogram e 
with b and c. From these results, we can conclude that M67 
does not block I3 binding to DP. Monoclonal antibody M67 can 
therefore be used as a capture antibody for absorption of DP 
molecules, so that I3 can be used for demonstrating the 
presence of these molecules on the beads. M58 completely 
blocks IJ binding to DP. This property can be used in this 
study for an indirect (blocking) demonstration of absorbed DP 
molecules. 
c. Blocking nonspecific fluorescence when using the 
metallic beads 
In this study, one problem with the use of FITC-
labelled I3 to demonstrate absorbed DP molecules was 
nonspecific fluorescence caused by direct binding of IJ to 
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Figure 3. cross blocking test 
M67 and M58 were tested to see 
if they block fluorescent 
antibody 13 
transfectant 
binding to DP 
cells. Panel a 
shows the cells that have not 
been exposed to the fluorescent 
antibody I3; panel b shows the 
positive 
blocking 
panel c 
control 
antibody 
serves 
in which no 
is added; 
as another 
positive control in which an 
irrelevant antibody is added 
before the fluorescent antibody 
I3 reacts with the cells; panel 
d shows that pre-incubation of 
M67 with the transfectant cells 
does not interfere with the 
binding of 13 to the cells, 
while panel e shows that the 
pre-incubation of M58 with the 
cells causes a failure of I3 to 
bind to the cells. 
* Mean fluorescence intensity 
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metallic beads. This occurred because IJ is a mouse IgG 
antibody and the metallic beads used are coated with a goat 
polyclonal antibody against all mouse IgG subclasses. To 
overcome this problem, affinity purified norn~al mouse IgG as 
well as normal mouse serum were tested respectively in serial 
dilutions for their ability to block nonspecific fluorescence. 
The metallic beads, after coating with anti-DP antibody, were 
incubated with purified normal mouse IgG or normal mouse 
serum, so that the unoccupied binding sites of goat 
immunoglobulins were filled with normal mouse IgG. Then the 
metallic beads were stained with I3 and examined for 
fluorescence using flow cytometry. The results are shown in 
Figure 4 (purified normal mouse IgG was used as blocking 
agent) and Figure 5 (normal mouse serum was used as blocking 
agent). Figure 4 shows that the metallic beads without being 
blocked had strong 
histogram b. When 
fluorescence, which is represented by 
purified mouse IgG was added, the 
fluorescence was blocked. As the amount of blocking IgG was 
reduced, the fluorescence gradually increased. The same effect 
can be seen in Figure 5. As normal serum was diluted, the 
fluorescence increased, indicating that the block became less 
complete. These results tell us that normal mouse serum or 
purified mouse IgG are effective for blocking nonspecific 
fluorescence. In all later experiments the beads were always 
incubated in mouse serum before 13 antibody was added. 
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Figure 4.Inhibition of non-
specific staining using normal 
mouse IgG 
This shows how the antibody-
coated metallic beads take up 
FITC-labelled I3 (anti-DP) non-
specifically even when there are 
no DP molecules on the beads 
(panel b). Panel a shows the 
negative control beads which 
have not been exposed to FITC. 
Panels c-g show how various 
dilutions of normal mouse IgG, 
added to the beads before IJ, 
inhibit this non-specific 
binding completely. The amounts 
of IgG added were 500~g(c), 
250JLg(d), 125JJ.g(e), 62.5JJ.g(f) 
and 31.25JJ.g{g). 
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Figure 5. Inhibition of non-
specific staining using normal 
mouse serum 
Normal mouse serum was used to 
block nonspecific staining of 
metallic beads by FITC-labelled 
IJ. Panel a shows the negative 
control beads which have not 
been exposed to FITC. Panel b, 
as in figure 4, shows 
nonspecific binding between IJ 
and metallic beads. Panels c-h 
show how various dilutions of 
normal mouse serum, added before 
IJ, inhibit this nonspecific 
binding effectively . 
* Mean fluorescence intensity 
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A.2 Absorption of DP molecules from cell lysates 
The procedure to obtain purified membrane molecules 
using affinity chromatography is finicky and time-consuming. 
In this study, we attempted to use metallic beads coated with 
antibody against an HLA-DP monomorphic determinant for 
absorption of DP molecules from cell lysates, to simplify the 
purification procedure. 
HLA-DP absorption was done by mixing metallic beads, 
coated with anti-DP antibody, with a cell lysate, followed by 
incubation overnight at 4°C. After that, the beads were 
examined for DP molecule absorption by staining with the 
fluorescent antibody IJ. The DP-absorption was estimated by 
quantifying the fluorescence using flow cytometry. As we did 
not have any knowledge about the cell numbers to be used for 
preparing cell lysates, or the amount of beads to be used for 
absorption, two experiments were done. 
In the first experiment, the effect of increasing the 
number of cells in the lysate was studied. Using a standard 
number of beads(lx106), absorptions were done in lysates made 
from lx105 , 5xl05 , lxl06 , 5x106 , lx107 and 1.5xl07 B cell line 
cells. As a control, the absorption was also done in a lysate 
made from lx106 normal mouse lymphocytes. One million metallic 
beads coated with an irrelevant antibody were used as another 
control. The results are shown in Figures 6a and 6b. It can be 
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Figure 6-a. Serial extraction 
of DP molecules using a 
stantard number of beads 
This 
shows 
experiment 
the uptake 
indirectly 
of DP mol-
ecules by a standard number of 
metallic beads ( lxl06 ) when they 
were placed in a standard 
lysate volume but made by 
lysing different numbers of 
cells. Panel a shows the 
negative control where the 
metallic beads had not been 
exposed to DP molecules. In 
panels b-g the number of cells 
(H0301 B cell line) lysed in 
each case are shown. Panel h is 
the result of using a mouse 
spleen cell lysate (106 cells) 
as a control. Panel i used an 
irrelevant coating antibody on 
the beads, which were then 
exposed to a lysate containing 
106 H0301 B cell line cells. The 
fluorescent antibody used to 
reveal bound HLA-DP molecules 
was !3. 
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Figure 6-b. Serial extraction of DP molecules using a 
standard number of beads (l million) 
54 
The absorption of DP molecules in lysates made of different 
numbers of cells were plotted. It appears that, as the cell 
number reached 5xl06 , the increase of absorption became less 
significant with further increases in cell number. 
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seen , from histogram b to g, that as the cell number in the 
lysate was increased, the absorption also increased. It is 
obvious in histogram h and i that the beads coated with anti-
DP antibody picked up very little in the mouse cell lysate and 
the irrelevant antibody coated beads also picked up almost 
nothing from the B cell line lysate. 
In the next experiment, two serial extractions from a 
lysate made from a standard number of B cell line cells 
(1x106 ) were performed, one with 2x106 metallic beads coated 
with anti-DP antibody, the other with 2X107 metallic beads 
coated with the same antibody. After five extractions, the OF-
absorptions were compared between the two groups. The results 
are presented in Figure 7. It can be seen from the change in 
the fluorescence intensity t.hat the lysate made from lx106 
cells allowed 2 million beads to do an effective extraction 
all 5 times. In order to have a reasonable density of DP 
molecules on each bead, 20 million beads seem to be too many 
for a lysate made from lx106 cells. 
A.J Indirect demonstration of absorbed molecules 
In order to identify DP molecules absorbed onto 
metallic beads more specifically, the following experiment was 
done. It was already known from a previous experiment that M58 
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Extraction Number 
• with 2x1 0 6 bends ~with 2x1 0 7 beads 
Figure 7. Serial extraction of DP molecules in lysates 
prepared with a standard number of cells 
This diagram shows the average amount of HLA-DP per 
extraction, assessed by FITC-labelled 13, when a standard 
lysate of H0301 B cells (106 total) was serially extracted 
by antibody coated beads. The solid bars show the result 
when 5 serial extractions were made using 2xl06 beads each 
time. The hatched bars show the result when 2x107 beads were 
used for each extraction. Fluorescent intensities represent 
values from which the background (negative control) 
intensities have been subtracted. 
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could effectively block IJ binding to HLA-DP. Since M58 is 
specific for DP polymorphic epitopes, the molecules blocked by 
it must be HL~-DP. 
The WTSl B cell line is homozygous for DPB1*0201, which 
is within the antigen repertoire of the M58 antibody. In this 
experiment, this cell line was used for preparing a cell 
lysate. The absorption of DP molecules was performed as 
described before. After that, the beads were blocked by 
incubating with M58. Then they were stained with !3. The 
fluorescence was examined using flow cytometry. The results 
are shown j n Figure 8, in which we can see a diminished 
fluorescence when absorbed beads were blocked by M58. This 
indicates that metallic beads had absorbed DP molecules onto 
then:. 
A.4. Demonstration of absorbed DP molecules by biotin-M67 
To identify DP molecules absorbed onto beads, another 
experiment was done, in which M58 was used as a capture 
antibody coated on beads and M67 labelled with biotin served 
as an indicator. M67 is known to be reactive with DP molecules 
but not with DR or DQ (on transfectants). Again, the WT51 B 
cell line was used for preparing a cell lysate. After immune 
absorption, the beads were stained by M67-biotin-avidin-FITC 
a 
Figure 8. Specific blocking 
test 
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A specificity test demonstrates 
that the FITC-labelled IJ is 
binding to HLA-DP molecules. 
Panel a is a negative control 
showing the staining with I3 of 
beads that had not been exposed 
to DP molecules. Panel b is the 
positive control where DP coated 
beads were stained with FITC-
labelled !3. Panel c shows the 
reduction of fluorescence when 
unlabelled M58 (anti-DP 
antibody) was added to the beads 
before the addition of FITC-
labelled I3. 
a 
c 
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Figure 9. Demonstration of DP 
by biotin-M67 
'!'he absorbed molecules on 
metallic beads were identified 
by biotinylated M67. Panel a 
shows the negative control 
beads; panel b shows the beads 
absorbed in a WT51 cell lysate 
which contains DP molecules; 
panel c shows the beads absorbed 
in a cell lysate (made from T 
cell line cells) that does not 
contain DP molecules. Only the 
beads absorbed in the DP-
cell lysate were containing 
stained hy 
FITC. 
M67-biotin-avidin-
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system. The results are shown in Figure 9. It can be seen that 
the beads absorbed in a WT51 cell lysate showed a distinct 
binding to biotinylated M67. This indicates that DP molecules 
were absorbed onto metallic beads. 
B. IMMUNOGENIC PROPERTIES OF BEAD-PURIFIED MOLECULES 
Using antigens attached to a carrier (like 
nitroc~llulose membrane, glass or agarose beads) to immunize 
mice has proven to be effective. In this study, we attempted 
to use HLA-DP molecules absorbed onto n\etallic beads as an 
immunogen to induce an antibody response to HLA-DP in the 
mouse. 
B.l Antigen dose response 
In order to establish a reasonable dose of antigen for 
use as an immunogen, two experiments were performed initially. 
Metallic beads lC'aded with DP molecules were injected in 
different doses into three groups of three mice each. The 
serum antibody responses were measured using cellular enzyme-
linked immunoassay (CELISA). The two experiments involved two 
different cell lines and somewhat different loading conditions 
for the beads. 
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The first experiment used the COX B cell line (see 
Materials and Methods). A lysate containing 8x107 COX cells in 
1.5 ml was used to load 2x108 beads by the method described 
earlier. Antigen loaded beads were injected subcutaneously 
into mice, a long with complete Freund's adjuvant ( CFA, see 
Materials and Methods), as follows: 3 mice received 2 million 
beads each; 3 mice received 10 million beads each and 3 mice 
were injected with 50 million beads each. Eighteen days 
following the primary immunization, tail-bleeding was done and 
the sera were tested against COX cells using the CELISA 
method. The results in Figure 10 show a clear dose response; 
for example, at the 1/24 dilution, the optical densities were 
50 million beads > 10 million beads > 2 million beads > non 
immune serum. 
The next experiment was essentially the same except 
that the SAVC cell line was used and the lysate this time 
contained 108 cells in 1. 5 ml. Figure 11 shows the same 
results as in Figure 10, the dose of 50 million beads caused 
a better antibody response than 10 million beads and 2 million 
beads. 
The conclusion from these experiments is that 50 
million beads are more effective than are smaller numbers, for 
evoking an antibody response in the mouse. 
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Figure 10. Immunogen dose response 
T 
n 
• -<.I 'L __ 
Data from an immunogen dose response determined by 
injecting Balb/c mice with different numbers of metallic 
beads that had been loaded with DP molecules from a lysate 
made from the COX B cell line. Eighteen days after the 
primary immunization, the sera were tested using the 
CELISA method. 
* The optical density of these dilutions exceeds 2.00. 
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This figure represents the same experiment as in figure 10 
except that the metallic beads were loaded with DP molecules 
from SAVC B cell line. 
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B.2. Antibody response following the secondary immunization 
Again, two experiments were performed, with different 
cell lines, to examine the secondary antibody response. 
In the first experiment, H0301 B cell line was used 
(see Materials and Methods). 4-6 weeks following the primary 
immunization that was done through subcutaneous injection of 
50 million DP loaded beads with CFA, the secondary 
immunization was performed by intraperitoneal injection of the 
same amount of beads with incomplete Freund's adjuvant. Three 
mice were done; one died of injury after the secondary 
injection. The sera were obtained through tail-bleeding one 
week after the secondary immunization and tested against H0301 
cells using the CELISA method. The results are shown in Figure 
12, in which a strong antibody response can be seen; at 1/48 
dilution, the OD value is still higher than 2. 
The second experiment using the WT51 B cell line was 
performed under the same conditions. The sera from three mice 
were diluted from 1/50 to 1/6400 for testing. Figure 13 shows 
that, at 1/1600 dilution, the antibody response was still 
distinctive. 
These results further indicate that DP loaded metallic 
beads are highly immunogenic. 
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Figure 12. Secondary antibody response 
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The secondary antibody response was determined on Balb/c mice 
one week following the second immunization with 5x107 metallic 
beads loaded with DP molecules from a lysate made from H0301 
B cell line cells. 
* The optical density of these dilutions exceeds 2.00. 
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Figure 13. Secondary antibody response 
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The secondary antibody response was determined on Balb/c mice 
one week after the ser<.>nd immunization with 5x107 metallic 
beads loaded with DP molecules from a lysate made from WT51 
cells. 
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B. 3. Comparison of beryllium sulphate and CFA, using DP 
molecules from L-cell transfectants as immunogen 
Beryllium sulphate is an alternative adjuvant, which 
has the interesting property of driving the immune response to 
produce IgG2 antibodies; this contrasts with complete Freund's 
adjuvant which tends to result in IgGl antibodies. The former, 
which activate complement are more useful for some purposes. 
In order to study its efficacy in promoting antibody responses 
in mice, beryllium sulphate and complete Freund's adjuvant 
were compared. Each of two adjuvants was used in separate 
primary immunizations with DP-absorbed beads. The comparison 
was performed in two groups of mice; one used CJH mice, the 
other used Balb/c mice. Each group was further divided into 
two subgroups, one with use of beryllium sulphate, the other 
with use of complete Freund's adjuvant. L-cell transfectants 
expressing HLA-DP were used this time in an attempt to use a 
potentially purer source of DP molecules. Since the L-cells 
are of CJH origin, the use of C3H mice is the ideal for this 
experiment. 
Two sorts of DP transfectant cells (DP8303 and DP8306) 
were used for preparing cell lysate. In the primary 
immunization, which was done through subcutaneous injection of 
antigen with beryllium sulphate or complete Freund's adjuvant, 
3.5xl06 DP8303 transfectant cells were lysed in 1.5ml to load 
4x108 beads; 4x108 DP8306 transfectant cells were lysed in 
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1. 5m1 to load 4 xl 08 beads. In each subgroup, two mice were 
immunized with DP8303 beads; two mice were immunized with 
DP8306 beans. 5x107 be~ds were injected into each mouse. Four 
weeks later, the sera were tested against transfectant cells 
using the CELISA method. The secondary immunization was done 
through intraperitoneal injection of the same dose of DP 
loaded beads with incomplete Freund's adjuvant. One week 
later, the secondary antl.body response was estimated using the 
CELISA method. 
The serum testing after the primary immunization did not 
show any significant antibody response in any group of mice. 
However, the secondary antibody response was obvious. The 
comparison of beryllium sulphate and complete Freund's 
adjuvant is given in Figure 14 (in C3H mice) and Figure 15 (in 
Balbfc mice) . It can be seen that, in both groups, the 
antibody response in the mice with use of complete Freund's 
adjuvant was higher than in the mice with use of beryllium 
sulphate. This suggests that complete Freund's adjuvant was 
more effective than beryllium sulphate in promoting antibody 
responses in the mice. 
B.4. Comparison of antibody responses to L cells and to 
transfectants 
Sera from the previous experiment were further tested 
using the CELISA method, in order to see how much of the 
.·, 
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Figure 14. Comparison of BeS04 and CFA in C3H mice 
The influence of beryllium sulphate and complete Freund's 
adjuvant on antibody response was compared in C3H mice. In the 
primary immunization, both adjuvants were respectively used 
with metallic beads loaded with DP molecules in two groups of 
mice. In the secondary immunization the incomplete Freund's 
adjuvant was used in both groups of mice with the same dose of 
the beads. This diagram represents the secondary antibody 
response measured in both groups of mice one week after the 
second immunization. 
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The influence of beryllium sulphate and complete Freund's 
adjuvant on antibody response was compared in Balb/c mice. The 
immunization protocol is as same as in Figure 14, and the 
diagram shows a similar pattern. 
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reactivity was against L cell determinants and not against the 
DP molecules expressed on the transfectants. This was a not 
unlikely situation since the L-cells are of C3H origin and 
half of the immunized mice were Balbjc; these tnice differ at 
their H-2 loci, CJH being H-2k and Balbfc being H-2d. 
Figure 16 shows the comparison of antibody responses to 
L cells and to DP transfectants in C3H mice. It can be seen 
that there was considerable (and unexpected) reactivity to L-
cells, but the reactivity against DP transfectants was 
superior to L cells. Figure 17 shows the same comparison in 
Balbfc mice. It is obvious that, in Balbfc mice, the antibody 
response to DP transfectants cannot be differentiated from the 
response to L cells. This suggests that to induce an antibody 
response to DP, C3H transfectant cells may be more suitable 
for use in CJH mice than in Balbfc mice. It also suggests that 
antibody coated beads could pick up things other than human 
class II molecules. 
C. CENTRIFUGAL-ELECTROFUSION (CEF) OF IMMUNOMAGNETICALLY 
SELECTED SPLEEN CELLS 
The production of mouse hybridomas is usually 
accomplished through fusion of mouse spleen cells with partner 
cells using the chemical fusagen, polyethylene glycol (PEG). 
~ 
Ul 
c: 
G) 
0 
5 
a 
0 
72 
1.5r-------------------------------------------------------~ 
0 .6 
0 
1/50 1/100 1/200 1/400 1/800 1/1600 1 /3200 1/6400 
Serum Dilution 
• Normal control liiiD Reaction to L-cell [1 Reaction to TF cell 
Figure 16. Serum antibody specificity in CJH mice 
The antibody responses to L-cells and to L-cell DP 
transfectants were compared in CJH mice. As the serum was 
diluted, the reactivity against DP transfectants became more 
distinctive. 
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Figure 17. Serum antibody specificity in Balb/c mice 
The antibody responses to L-cells and to L-cell DP 
transfectant cells were compared in Balbjc mice. The 
reactivitiy to L-cells and to DP cannot be distinguished from 
each other. 
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Usually 1X108 spleen cells, or more are· required for each 
fusion. If one could use a selected subset of spleen cells 
(such as antigen-specific B lymphocytes or IgG-bearing B 
lymphocytes) for fusion to partner cells, the labour of 
fusion, growth and screening of hybridomas would be greatly 
reduced. Meanwhile, the proportion of positive hybridomas 
should also be increased. Since, for most subsets, the number 
of selected spleen cells is too small for a standard PEG 
fusion, the centrifugal-electrofusion (CEF) method is 
preferable to the PEG fusion method. 
The expe~iments in this section are based on an 
immunomagnetic fractionation principle using either antigen-
coupled metallic beads or else metallic beads coupled to anti-
mouse IgG. As the separation of IgG bearing B lymphocytes is 
easier technically than the separation of antigen-specific B 
lymphocytes, centrifugal-electrofusion of the IgG bearing 
spleen cells was the first method to be tried. 
C.l. CEF of cells selected f or surface expression of IgG 
In this group of experiments, mouse s pleen cells were 
collected and incubated with metallic beads coated with goat 
anti-mouse IgG (all subclasses) at 4°C for one hour. Then the 
cells bound •-,...::tds were separated us i ng a magnet. The 
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selected spleen cells, still mixed with beads, were fused with 
SP2/o myeloma cells using centrifugal-electrofusion. After 
fusion, the cells were plated in 96-well culture plates with 
flat bottomed wells. Appropriate numbers of remainder cells 
(i.e. those remaining after the bead selection is completed) 
and unsorted spleen cells from the same spleen cell suspension 
were fused for comparison. Thus for each experiment, there 
were three fusion groups, 1) the selected cells; 2) the 
remainder cells; 3) the unsorted spleen cells. 
a. Optimizing the conditions for hybridoma growth 
Sixteen centrifugal electrofusions of cells selected 
for IgG expression were performed in an attempt to obtain 
hybridornas. Different conditions were tested in some 
experiments. The results are summarized in Table 1. Details of 
individual experiment are given in the appendix. 
In fusioiJS 1-2, the ratio of anti-mouse IgG metallic 
beads to spleen cells was 3: 1 and 2: 1 respectively. After 
fusion, when the cells were plated in 96-well culture plates, 
it was found Lhat there were so many beads in each well that 
the cells could not be seen. No hybrids grew in any of the 
wells. 
In fusions 3-5, the ratio of metallic beads to spleen 
cells was reduced to 1:2. The fused cells could now be 
observed in the 96 well plate. Some hybridoma colonies 
Table 1. Summary of the centrifugal electrofusion trials using spleen cells sel ected 
with IgG-coated metallic beads. 
Fusion Mice Ratio of Selected Cells Feeder Results Note 
Number Beads per from Spleen Cell 
Spleen Population: Layer 
Cell 
Number Percent 
#1 C3H 3:1 1. Oxl07 5% m RBC no growth bead layer 
too thick. 
#2 C3H 2:1 3. 6xl06 2% m RBC signs of bead layer 
hybrids, but too thick. 
no growth 
#3 C3H 1:2 2. 5xl07 17% m RBC no growth 
#4 C3H 1:2 5. 3x106 1.6% m PMC signs of 
C3H 1. 5x107 7.0% hybrids, but 
no growth 
#5 Balbfc 1:2 4. 4xl07 20% m RBC some hybrids only in 
grew, then remainder & 
died unsorted cell 
groups 
#6 Balb/c 1:2 1. 9x1o7 7% m RBC no growth voltage was 
not 
appropri ate 
#7 Balbjc 1:2 1. Ox107 7% m PMC some grew, influence of 
but sucrose was 
. contaminated tested 
Table 1. (continued ... ) 
Fusion Mice Ratio of Selected Cells Feeder Results Note 
Number Beads per from Spleen Cell 
Spleen Population: Layer 
Cell 
Number Percent 
#8 Ba1bjc 1:2 2. ax1o7 23% m PMC no growth influence of 
sucrose was 
tested 
#9 Balb/c 1:2 1. 5x107 11% m RBC no growth pre-
m PMC incubation 
was tested 
#10 Balb/C 1:2 7. 0x106 4% m RBC sign of taken care of 
hybrids, but by other 
no growth person 
#11 Ba1bjc 1:3 5. OX106 2% m RBC hybrids grew reduced HAT 
concentration 
#12 Balbjc 1:5 9. 3x106 5% m RBC hybrids grew reduced HAT 
concentration 
#13 Balbjc 1:5 3. 5x106 1.4% m RBC hybrids grew reduced HAT 
concentration 
#14 Balbjc 1:3 7. sx106 5% m RBC hybrids greH reduced HAT 
concentration 
#15 Balb/C 1:3 1. 4x107 5.6% m RBC hybrids grew reduced HAT 
concentration 
#16 Balb/C 1:3 2. 2x1o7 11% m RBC hybrids grew reduced HAT 
concentration 
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appeared by day 7-10 after fusion in fusion 5 but they died 1-
2 days later. 
In fusion 6, the voltage for fusion was not appropriate 
due to equipment failure. There was no growth of hybridomas. 
In fusions 7-10, attempts to improve the conditions for 
hybridoma growth were made. In fusion 7 and 8, after the 
centrifugal-electrofusion, half of the fusecl cells were washed 
twice with culture medium to remove any excess of the low 
ionic strength fusion buffer; the other half were plated 
directly without washing. In fusion 9, half of the fused calls 
were incubated at 37°C for 45 min, then plated; the other half 
were directly plated without incubation. In fusion 10, the 
possible influence of technical skill was tested by leaving 
the fused cells in the care of an experienced technician 
(instead of this graduate student). All these attempts failed 
to show any differences between two test groups. 
Peritoneal macrophage cells were used as feeder cells 
in fusion 4, 7, 8 and 9; they did not appear to lead to any 
improvement in cell growth. 
In fusions 11-16, attention was shifted onto the HAT 
medium used for feeding fused cells as a possible cause for 
poor cell survival. The modification introduced in fusion 11-
16 was to reduce the concentration of HAT to half of the 
conventional concentration. A plate of SP2/o myeloma cells was 
set up as a control, to show that this HAT concentration was 
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still 100% inhibitory to them. The SP2/o cells were fed with 
the same HAT medium at the same time as the fused cells were 
fed. When all of the SP2/o cells died in the control plate, 
the HAT medium was changed to HT medium. In these experiments, 
the ratio of metallic beads to spleen cells was reduced 
further to 1:3 and 1:5. With these modification~~ fusions 11-
16 began to grow hybridomas. The growth and screening of these 
hybridornas are summarized in Table 2 and discussed in the 
following section. 
b. Screening of the hybridomas 
In fusions 11-16, the spleen cells were all from mice 
immunized with metallic beads which were supposedly loaded 
with DP2.1 molecules; the cell lysate had been made from the 
B cell line, WT51. The specificity of the hybridomas that grew 
was examined using the CELISA method. 
The first screening, using WT51 B cell line cells (the 
immunogen), was considered a general selection. Positive 
hybridornas were counted and selected for further screening. 
In the second screening, transfectant cells expressing 
diff~rent DP, DQ or DR molecules were employed as targets. 
This screen differentiated various antibodies with monomorphic 
specificity (anti class II HLA, anti all DP, anti DP and DR), 
and also revealed certain antibodies which r·eacted with 
polymorphic determinants on a number of DP molecules. However, 
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it should be mentioned here that the selection of specific 
hybridomas with possible polymorphic specificity was based on 
a relatively low optical density (OD) value as a cut off 
(>0.15). 
In the third screening, tne hybridornas selected from 
the second screen as being specific for DP transfectants were 
examined using a panel of homozygous B lymphoblastoid cell 
lines. 
The results of fusions 11-16 and the outcomes of 
specificity screening are presented in Table 2. We can see, 
from the table, that fusions 12 and 15 were generally 
unsuccessful and were terminated at the end of the second week 
after fusion without any screening. In fusions 14 and 16, the 
first screen did not show the expected results; those too were 
terminated. Fusions 11 and 13 appeared productive. Many 
hybridomas were positive, particularly in the first screening. 
From these data the two ratios required for columns 7 and 8 
of the table could be calculated; these are 1) the number of 
hybrids positive in the second screening per million cells 
fused and 2) the frequency of immunogen specific hybrids in 
relation to the total number of hybrids. 
It is of interest to note that in both experiments 
where a reasonable number of hybrids was produced (fusions 11 
and 13), a higher proportion of immunogen-specific cells was 
found with the metallic bead selected spleen cells. Thus the 
Table 2. Growth and screening results of the hybridomas 
Fusion Number Total No. of +ve No. of No. of Ratio of Percent of 
Number of Number hybrids hybrids +ve hybrids hybrids 
Fused of from spec. hybrids spec. for spec. for 
spleen hybrids Scrn 1 for from class II class II 
cells formed (immunogen) class II Scrn 3 over total over total 
(Tfs, (B-cell # cells # hybrids 
scrn 2) lines) fused 
#11 Sel. 64 61 15 3 2. 9/106 23% 
5. 2x106 
Rem. 87 3 1 1 0.1/106 1.1% 
1x107 
Uns. 73 4 1 0 0.1/106 1.3% 
1x107 
#12 Sel. 0 
9. 3x106 
Rem. 5 not tested 
9. 3x1o6 
Uns. 0 
9. 3x106 
#13 sel. 57 13 7 1 2/106 12% 
3. 5x106 
Rem. 87 11 6 2 0. 85/1.06 6.8% 
7x106 
Uns. 89 9 5 1 0. 7/106 5.6% 
7x106 
Table 2. (cont1nued •.. ) 
Fusion Number Total No. of +ve 
Number of Number hybrids 
Fused of from 
spleen hybrids Scrn 1 
cells formed (immunogen} 
#14 Sel. 9 -ve 
7. 8x106 
Rem. 11 -ve 
7. 8x106 
Uns. 11 -ve 
7. 8x106 
#15 Sel. 0 
1. 4Xl07 
Rem. 0 
1. 4Xl07 
Uns. 5 not tested 
1. 4xl07 
#16 Sel. 7 -ve 
2. 2x1o7 
Rem. 1 -ve 
2 . 2xl07 
Uns. 66 8 
2. 2X107 
No. of No. of 
hybrids +ve 
spec. hybrids 
for from 
class II Scrn 3 
(Tfs, (B-cell 
scrn 2) lines) 
not 
tested 
Ratio of 
hybrids 
spec. for 
class II 
over total 
# cells 
fused 
Percent of 
hybrids 
spec. for 
class II 
over total 
# hybrids 
co 
N 
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selective procedure, although only for IgG positive cells, 
appeared to enrich for the cells of particular interest. 
The hybridomas selected after the third screen were 
given to the immunology lab and the antibodies were tested 
against human peripheral blood B lymphocytes, using flow 
cytometry. surprisingly, the supernatants ~id not show much 
reaction with B lymphocytes derived from blood samples. The 
same situation has been found in some other experiments in 
this lab; the discrepancy is not yet explained. 
Conclusions from this series of experiments are 
twofold. First, they suggest that the metallic beads have 
picked up immunogenic DP molecules; second they show, in a 
preliminary fashion, that sorting IgG positive cells may, in 
a secondary response, be a useful way to select out immunogen 
reactive B cells for fusion. 
C.2. Fusion of spleen cells fractionated with antigen 
coupled metallic beads 
Sev~ral attempts to fuse spleen cells that had been 
selected using antigen coupled metallic beads were made. 
Metallic beads were coupled to DP molecules through physical 
absorption using a cell lysate made from WT51 B lymphoblastoid 
cell line cells . The DP- loaded beads were incubated with 
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immune spleen cell suspensions for one hour at 4°C. The spleen 
cells bound to beads were separated and fused to SP2/o myeloma 
cells using the centrifugal electrofusion technique. Three 
fusions were performed, which are surr.marized in Table 3. 
Fusion 17 did not produce many hybrid3 in the selected cell 
group; screening using WT51 B cell line cells as the target 
showed negative results. Fusion 18 only grew se·:eral 
hybridomas in control groups. The culture was terminated after 
two weeks. In fusjon J9, hybridomas were produced in all three 
groups; unfortunately, the cultures were contaminated after 
preliminary testing had shown them to be positive for the 
immunizing cell; they were all lost. 
The conclusion to these antigen-specific experiments is 
that, when all components of the technology are working 
satisfactorily, it appears that significant enr ichrnent for 
antigen specific hybridomas is possible. 
Table 3. Fusions of the selected cells fractionated by antigen coupled metallic beads 
Fusion Mice Immunogen Ratio Number Percent of Number Number (and %) 
Number of of spleen of of +ve hybrids 
beads fused cell hybrids to immunogen 
to Cell cells population 
#17 Balbfc Metallic 1:5 Sel. 1. 5% 3 -ve 
beads 3Xl06 
loaded 
with DP Rem. 34 -ve 
molecules 6xl06 
from WT51 
B-cell Uns. 16 -ve 
line 6Xl06 
#18 Balb/C Metallic 1:5 Sel. 1. 6% 0 
beads 2.5Y.l06 
loaded 
with DP 
not tested molecules Rem. 4 
from WT51 5Xl0
6 
B-cell Uns. 2 not tested line 
5xl06 
#19 Balb/C Metallic 1:5 Sel. 1.8% 17 9 (53%) 
beads 3. 7xl06 
loaded 
with DP Rem. 26 2 (8%) 
molecules 7xl06 
from WT51 
B-cell Uns. 34 5 (15%) 
line 7x106 
co 
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DISCUSSION and CONCLUSIONS 
study the investigation 
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of using 
immunomagnetism in hybridoma production was done in three 
general parts: 1) antigen preparation, 2) immunization, 3) 
electrofusion of selected spleen cells. The discussion will be 
focused on the results of the experiments in these three 
parts. 
~SELECTION OF APPROPRIATE ANTIBODIES 
At the beginning of this study, the preliminary work 
involved ( i) choosing a capture antibody for immune absorption 
of HLA-DP molecules and ( ii) developing an antibody-based 
indicator system. As both antibodies had to bind to the same 
molecule, it was imperative that they should not block each 
other. 
A commercially available fluorescent antibody, I3, was 
chosen as an indicator to demonstrate HLA molecules absorbed 
onto metallic beads. This choice was based on an antigen 
specificity analysis which showed that I3 bound only DP 
expressing transfectant cells. However, as it was only 
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possible to test a limited range of antigens in the analysis, 
any proof that HLA-DP molecules were present, using I3 could 
only be partial; complementary demonstrations would be 
required. 
The capture antibody was chosen through an experiment 
to test for cross blocking of antibody !3 (Drover et al. 
1991) . Results of the experiment . provided two favourable 
conditions for the subsequent study of absorbed molecules. 
First, M67 specific for a monomorphic determinant on HLA-DP 
was shown not to block IJ. This made M67 an ideal capture 
antibody that could be immobilized on metallic beads. Second, 
M58 was found to be a potent blocker of I3. This property 
provided a useful tool to confirm the presence of absorbed DP 
molecules. M58 is specific for an HLA-DP polymorphism, if a 
known interaction between the fluorescent antibody I3 and its 
target molecules could be blocked by M58, the target molecules 
would by inference be HLA-DP. 
From the cross blocking tests, it can also be concluded 
that M67 and M58 will not block each other since they were 
shown in the experiment to bind to different locations of the 
same DP molecule. This property was used later for a direct 
demonstration of the presence of absorbed DP molecules on 
beads, in which M67 was labelled with biotin-avidin-FITC, 
while M58 acted as a capture antibody. 
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B. ABSORPTION OF DP MOLECULES 
DP absorption from cell lysates onto metallic beads was 
done in two serial extraction experiments. In the first one, 
a standard number of beads was shown to have a gradual 
increase of absorbed DP molecules as the cell number in the 
cell lysates was increased. In the second one, serial 
absorptious were performed using a lysate made from a standard 
number of cells. When a large number of metallic beads was 
used, a low absorption density was noted, as compared with the 
use of a small number of beads, indicating a relative shortage 
of target molecules in the cell lysate. Although the two 
experiments can not be counted as quantitative, an approximate 
ratio for an effective use of metallic beads and cells in 
immune absorption of DP molecules can be inferred from the 
data. Using a B cell line for preparation of the lysate, 
reasonable saturation of the beads was shown when I used 1x106 
cells in the lysate and added about 2x106 beads. 
The measurement of DP molecules on cell membranes or in 
cell lysates, on a weight basis, was not done in this study. 
Such a determination would be quite difficult because the DP 
expression is considered to be at a low level. An approach to 
quantify DP molecules could probably be made by the serial 
extraction method. It was shown that with the use of a large 
number of metallic beads for the absorption, the DP molecules 
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in a cell lysate could be completely absorbed. If total 
protein eluted from DP absorbed beads and total protein from 
a matching lot of unabsorbed beads could be determined, the 
amount of DP molecules could be calculated by subtraction. The 
problem is that in both cases there would be immunoglobulin 
released which would give a significant background reading. 
The specific absorption of DP molecules by metallic 
beads was shown by three experiments. In the first one, the 
metallic beads were coated with M67; the absorbed molecules 
were identified by FITC-labelled antibody 13. It was noted 
that the fluorescent antibody 13 only stained the beads that 
had been absorbed in a cell lysate containing DP molecules: it 
did not stain beads that had been absorbed in a lysate lacking 
DP molecules, nor when the beads were coated with an 
irrelevant antibody. This provides good evidence that the 
anti-DP antibody coated metallic beads made a specific 
absorption from a B cell line cell lysate. 
In the second experiment , the specific absorption was 
confirmed by the M58 blocking test, in which the metallic 
beads with absorbed molecules were first incubated with M58, 
then stained by fluorescent antibody 13. As mentioned before, 
M58 is specific for a DP polymorphism; thus if the binding of 
the fluorescent antibody 13 and the absorbed molecules is 
blocked by M58, this is highly suggestive that the absorbed 
molecules on metallic beads should be DP. 
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The third experiment provided direct evidence that the 
metallic beads absorb DP specifically. In this experiment, M58 
as a capture antibody was coated onto metallic beads, while 
M67 was conjugated with biotin, serving as an indicator. As 
both antibodies are DP specific, there is no doubt that the 
molecules identified on metallic beads are DP molecules. 
It was supposed that some non-specific binding of DQ 
and DR class II molecules or other non-MHC antigens might 
occur in "DP specific absorptions" as a result of some 
portions of cell membrane with embedded membrane molecules 
being incompletely reduced in the lysate and present in the 
form of micelles. Thus, all kinds of :nembrane proteins would 
likely be picked up by the beads. This problem was prevented 
in the DP absorption experiment by an immediate washing of 
metallic beads with fresh lysing buffer after the absorption 
had been completed. 
C. IMMUNIZATION 
The use of metallic beads absorbed with HLA-DP 
molecules for immunization was prompted by two advantages. 
Firstly, the immunogenicity of small doses of such molecules 
is increased by this procedure (Goding 1986, Nilsson et al. 
1990). Secondly, the preparation of antigen by this method is 
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less time-consuming since the procedure of elution and 
dialysis of the purified molecules is eliminated. Antisera 
from the immunized mice were tested by assessing their 
reaction with the cells that had been used for preparation of 
antigens. The antibody response was seen clearly. Ideally, the 
specificity of antibodies in these antisera should be tested 
to determine how much of the reaction was against HLA-DP and 
how much to other B cell molecules including HLA-DR and -DQ. 
However, as much of the response would be against monomorphic 
determinants on these molecules, it would be very difficult to 
quantify the response among these molecules. For this and 
other reasons it was decided not to attempt such an analysi~. 
In a comparison between the use of beryllium sulphate 
and complete Freund's adjuvant, a s i gnificant primary antibody 
response was not shown. However, there was a clear difference 
in antibody titre between two groups in the secondary antibody 
response, although in the secondary immunization no beryllium 
sulphate or CFA was used. As the difference between the two 
groups of mice is consistent, we attribute it to the influence 
of the two adjuvants used in the primary immunization. 
Freund's adjuvant gave the better result. 
It is known that the beryllium sulphate is a 
carcinogenic chemical compound. This was revealed in the 
present study. Three out of the eight mice that received 
beryllium sulphate as an adjuvant developed tumours later at 
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the site of injection. The malignancy was confirmed by 
histopathological study of the tumours. This is a further 
reason for preferring Freund's complete adjuvant. 
L cells, which are of C3H origin, have been found to 
cause a weak antibody response in C3H mice, whether in this 
laboratory or in this study. The reason for this phenomenon is 
uncertain. However, since the L cells are mutants of tumour 
type of fibroblasts, there could possibly be some variances in 
the composition of the cell membrane molecules. 
D. PRE-FUSION CELL SELECTION 
The use of metallic beads for pre-fusion cell selection 
of specific spleen cells is a relatively unexplored approach 
to hybridoma creation. So far, the only reported study of this 
approach has been that of Egeland et al. ( 1988) , in which 
rabbit IgG coupled metallic beads were used to rosette 
rheumatoid factor positive B lymphocytes. The rosetted cells, 
after having been transformed with Epstein-Barr virus for bulk 
expansion, were fused with myeloma cells. The usefulness of 
Egeland's method is limited because cells other than human B 
lymphocytes cannot be transformed with EB virus for 
amplification, while on the other hand the routine method of 
PEG fusion is only applicable to large numbers of cells. The 
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centrifugo-electrofusion facility devised by the immunology 
laboratory of Memorial University of Newfoundland provided an 
excellent tool for the fusion of a small number of cells and 
made the exploration of specific fusion of selected mouse 
spleen cells possible. In this study, pre-fusion cell 
selection was investigated in two groups of experiments. One 
was with the use of goat anti-mouse IgG (GAM) coupled metallic 
beads, the other one was with the use of the specific antigen, 
HLA-DP molecules, coupled to metallic beads. 
0.1. Selection of IgG bearing cells 
GAM-IgG coupled metallic beads were used in an attempt 
to rosette IgG expressing lymphocytes in spleen cell 
suspensions. Previous reports suggested that the ratio of 
metallic beads to cells for positive cell selection should be 
3 to 1. However, we found in this study that such a ratio 
caused a thick layer of beads to form on the bottom of cell 
culture wells, which completely obscured observation of the 
fused cells. A ratio of one bead to three or five cells was 
adopted in later experiments. Various yields of selected cells 
were shown in cell fractionations, but no consistent tendency 
could be seen in these fluctuating data. This makes a comment 
on the efficiency of the metallic beads in the cell 
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selections difficult. To solve this problem, a specific 
analysis of the number of cells expressing IgG molecules in 
spleen cell suspensions would be required before and after 
cell selection, as well as checking the purity of the selected 
cells. Flow cytometry would be good for this purpose. 
A relatively higher percentage of positive hybridomas 
was achieved in the fusions of the selected spleen cells, 
suggesting that the positive hybridoma frequency could be 
increased by specific fusion of the IgG expressing 
lymphocyte-s. This is possible since, as the fusions were 
performed on the third day after boost immunization, most 
antigen-specific lymphocytes should be among the population of 
cells e~pressing IgG. 
To evaluate the selection of IgG bearing cells, an 
antibody isotyping test would be interesting. Theoretically, 
most antibodies from the fusion of the cells selected by GAM-
IgG beads are IgG isotype, while those from the fusion of the 
remainder cells are mostly IgM isotype. Future experiments of 
this nature should include isotyping. 
0.2. Selection of antigen-specific lymphocytes 
Selection of DP-specific B lymphocytes was made by 
using HLA-DP coupled metallic beads. This should be more 
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difficult than the selection of IgG bearing lymphocytes since 
the number of the target cells in a spleen cell suspension is 
much smaller. The data from the experiments in this study are 
fragmentary. However, in one of the fusions of the cells 
selected with DP antigen coupled beads, a higher percentage of 
positive hybridomas was produced than j~ the control fusions. 
This is a hopeful finding to encourage further explorations. 
E. GROWING ELECTROFUSED HYBRIDOMAS 
The growth of hybridorna cells in this study went 
through an initial period of difficulty. In the first ten 
fusions the hybridornas had died one to two weeks after the 
fusion for no detectable reason. Two factors were considered 
to be the cause of this phenomenon. Mycoplasma contamination 
is assumed to be one important factor, as at a later stage of 
this study, mycoplasma was identified in several cell lines in 
this lab, including the fusion partner line, SP2jo. Mycoplasma 
has been commonly found to be the major agent in cell culture 
contamination in many laboratories. Mycoplasma infection has 
been shown to affect the ability of cells to form hybridomas 
(Goding 1986). However, the way in which mycoplasma infection 
causes cell death is not certain. It is also not known why 
such contamination causes hybridoma death, but not death of 
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established cell lines. 
A second factor that was considered in the search for 
the cause of hybridoma death was the concentration of HAT in 
the cell culture medium. Hybridomas finally grew in a medium 
with a reduced concentration of HAT, suggesting that the 
concentration of the HAT might play a role in the failure of 
the hybridoma growth. Considering both factors together, It 
is not impossible that mycoplasma contamination not only 
interferes wlth hybridoma growth but also causes the hybridoma 
to be excessively vulnerable to the toxicity of HAT medium. It 
would be rewarding to do a series of experiments in which 
electrofused cells are separately grown in several kinds of 
medium with different concentrations of HAT. 
Malfunction of the electrical apparatus has been an 
occasional cause of failure in fusion experiments in this lab. 
Other studies on electrofusion in the same lab have shown that 
the voltage, pulse duration and cell number all affect 
hybridorna formation. However, up to now no evidence has been 
found that electrical factors could cause formed hybridomas to 
die. 
A slightly different way to plate fused cells was used 
in some of the fusion experiments in this project. It was 
noted that in several fusions, due to the small number of 
selected spleen cells, there were only enough cells to plate 
a few culture wells when the standard number of cells per well 
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(1.5x105) was adhered to. The number of metallic beads i~ each 
well was relatively increased and this may have inhibited 
hybrid growth and also prevented detection of the hybrids . 
The fused cells were finally plated in more wells than the 
usual, with slightly less than 1x105 cells per well. In order 
to avert the negative effect of small number of cells in each 
well on hybrid growth, sufficient non-fused spleen cells were 
added so that the number of 1. 5xlo5 cells was kept in each 
well. The successful growth of hybrids in these plates 
confirmed this plating method's feasibility. 
F. SCREENING HYBRIDOMAS 
study of the specificities of some of the monoclonal 
antibodies that were produced from these experiments is 
important in so far as these reflect on the effectiveness of 
the methods employed. In particular the finding of anti-DP 
antibodies supports the idea that immunisation with DP 
absorbed onto beads was effective. In addition, the proof o f 
the value of the cell selection experiments (pre-fusion 
selection) lies in the yield of hybridomas with anti-DP 
specificity. The specificities found at each level of 
screening are now discussed. 
The hybridomas were examine d in three screeniny ~;. The 
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first was a general selection in which all hybridornas roacting 
with the cells that had been used for preparation of 
irnrnunogens were selected. Although DP specificity cannot be 
distinguished in this screening, the higher percentage of 
positive hybridomas produced by 
cells is helpful in assessing 
selection of immune spleen cells. 
fusion of selected spleen 
the effect of pre-fusion 
The second and third screenings were specificity 
assays. In the second, DQ, DR and DP transfectant cells were 
used as targets. Identification of potentially useful 
hybridomas at this sta~c is based on an overall balance of the 
optical density recorded and on the preliminary determination 
of antibody specificity. Some hybridomas having a high 00 
value in the assay but not showing specificity for a DP 
polymorphism were not selected for further study. Only those 
specific for DP transfectants were picked. It was noted that, 
sometimes, the antibodies showing weak affinity for 
transfectant cells had a go~d reactivity with B cell lines. 
The reason for this is not known. Since the expression of HLA-
DP on cell lines is more natural than it is on transfectants, 
further specificity information was obtained by studying the 
antibody's reactivity to B cell lines. 
Hybridornas showing specificity for either DP 
polyrnorphisrns or class II rnonornorphisrns were counted in each 
successful fusion. This hybridorna frequency was found to be 
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higher in the fusion of selected spleen cells than in the 
control fusions of remainder or of unsorted spleen cells. This 
result confirmed the feasibility of the pre-fusion selection 
method in hybridoma production. Moreover, the DP specificity 
of these hybridomas provided further direct evidence that DP 
molecules absorbed onto metallic beads can be used to provoke 
an antibody response in mice. 
G. CONCLUSIONS 
Metallic beads were used at many points in the course 
of monoclonal antibody production, from antigen preparation to 
hybridoma formation. The advantage of using metallic beads in 
each procedure is evident. As the metallic beads can be 
manipulated with a magnet, all the proc~dures that involve 
their use become convenient and time saving. Metallic beads 
coated with specific antibody are effective in immune 
absorption of HLA-DP molecules from cell lysates. This was 
confirmed by the demonstration of DP molecules using the 
fluorescent antibody I3, and by use of a combination of the 
antibody M58 and biotinylated MG7. Metallic beads carrying 
absorbed DP molecules are immunogenic. This was shown in the 
antiserum testing. With the direct use of DP molecules 
absorbed onto metallic beads, the cumbersome procedures of 
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elution and dialysis of purified antigen molecules were 
eliminated. The use of metallic beads for pre-fusion cell 
selection is feasible. Although there is no available data to 
show directly the efficacy of these beads on selection of IgG-
expressing or untigen-specific lymphocytes in a spleen cell 
suspension, the higher frequency of positive hybridomas 
produced in this project, in the fusions of the selected 
spleen cells, indicates that the application of these beads to 
pre-fusion cell selection is a possible way to improve the 
frequency of antigen-specific hybridomas. 
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APPENDIX 
Fusion 1. Mouse: C3H 
24/07/91 Antigen: 5xlo7 metallic beads that had been absorbed 
in a cell lysate made from DP-expressing 
transfectant cells (DPB1*0901) in primary, 
secondary immunization, as well as in pre-fusion 
boost. 
Spleen cells: 1.9x1u8 
Cell selection: About 6x108 metallic beads coated 
with GAM-IgG antibodies were mixed with spleen 
cells. After an incubation at 4°C for half an hour, 
about. 1x107 cells were pulled out (only rosettes 
were counted). 
SP2/o cells: 4x106 
Fusion conditions: Half the selected cells were 
fused with SP2/o cells covering on the bottom of 
fusion chamber (2 pulses, 2.25kVjcm and 100~Sec in 
each one) ; another half cells were fused in a cell 
mixture manner (2 pulses, 2.25kVjcm and lOO~Sec in 
each one). 
Feeder cells: Normal mouse red blood cells 
Plated cells: In 2x70 wells, 1x105 cells per well. 
Results: No growth: the layer of metallic beads 
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looked thick. Control fusions of remainder cells and 
unsorted spleen cells were not done. 
Fusion 2. Mouse: C3H 
26/07/91 Antigen: 5xl07 metallic beads that had been absorbed 
in a cell lysate made from DP-expressing 
transfectant cells (DPB1*0901) in primary and 
secondary immunization. 2xl07 transfectant cells of 
the same nature in pre-fusion boost. 
Spleen cells: 1.8xto8 
Cell selection: About J.6xl08 metallic beads coatert 
with GAM-IgG antibodies were mixed with those spleen 
cells. After an incubatio~ at 4°C for half an hour, 
about 3.6xlo6 cells werG pul l ed out (only rosettes 
~vere counted) . 
SP2/o cells: 1.8xl06 
Fusion conditions: All the cells were fused with 
SP2/o cells covering on the bottom of fusion 
chamber. Two different pulses were delivered, one 
was 2.23kV/cm, lOO~Sec; the other one was 2.23kVjcm, 
200~Sec. 
Feeder cells: Normal mouse red blood cells 
Plated cells: In 50 wells, 1x105 cells per well. 
Half the fused cells were put in a magnetic field 
after fusion, in an attempt to separate the cells 
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from the metallic beads. Another half cells were 
plated directly, without the magnetic separation. 
Results: No growth. The layer of metallic beads 
looked thick. Control fusions of remainder cells and 
unsorted spleen cells were not done. 
Fusion 3. Mouse: C3H 
05/08/91 Antigen: 5x107 metallic beads that had been absorbed 
in a lysate made from OF-expressing transfectant 
cells (DPB1*0401) in primary and secondary 
immunization, as well as in pre-fusion boost. 
Spleen cells: 1.4x108 
Cell selection: About 7x107 metallic beads coated 
with GAM-IgG antibodies were mixed with those spleen 
cells. After an incubation at 4°C for one hour, a 
total of 2.5x107 cells were pulled out. 
SP2/o cells: 5xl06 
Fusion conditions: The fusion was done in a cell 
mixture manner, with 2 pulses, 2. 25kVjcm and 100J,£Sec 
in each one. 
Feeder cells: Normal mouse red blood cells. 
Plated cell: 1x105 per well. Half the fused cells 
were incubated in a flask overnight. lOml of an 
irrelevant antibody supernatant (M2, IgG isotype) 
was added into the flask in an attempt to detach the 
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beads from the cells. Then they were plated. 
Results: No growth. Control fusions of unsorted 
cells and remainder cells were not done. 
Fusion 4. Mouse: C3H (2 mice) 
09/08/91 Antigen: sx107 metallic beads that had been absorbed 
in a lysate made from DP-expressing transfectant 
cells ( DPBl *0901, or DPBl *04 01) in primary and 
secondary immunization, as well as in pre-fusion 
boost. 
Spleen cells: 3. 4x:l03 (mouse one) ; 2. 2x:l08 (mouse 
b/0) 
Cell selection: Half of the 3. 4xl08 spleen cells 
(mouse one) were mixed \olith about 8xl07 metallic 
beads coated with GAM-IgG antibodies. After an 
incubation at 4°C for one hour, a total of 5.3x1o6 
cells were pulled out. Half of 2.2x108 spleen cells 
(mouse two) were mixed with about 5xlo7 metallic 
beads coated with GAM-IgG antibodies. After an 
incubation at 4°C for one hour, a total of 1.5xl07 
cells were pulled out. 
SP2/o cells: (1) 1. 3xl06 to 5. 3x106 selected spleen 
cells; ( 2) 3. 8xl06 to 1. 5xl07 selected spleen cells. 
Fusion conditions: Two fusions were done separately 
in a cell mixture manner. In each fusion, two 
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pulses, 2.25kVjcrn and lOOJ.LSec in each pulse were 
delivered. 
Feeder cells: Mouse peritoneal phagocytes. 
Plated cells: In 72 wells, about 1x1o5 cells per 
well. 
Results: Several wells had signs of hybrids, but 
there was no further growth. 
Fusion 5. Mouse: Balb/c 
05/09/91 Antigen: 5xl07 metallic beads that had been absorbed 
in a cell 
transfectant 
lysate made from 
cells ( DPB1 *0401) in 
OF-expressing 
primary and 
secondary immunization, as well as in pre-fusion 
boost. 
Spleen cells: 2.2x108 
Cell selection: 1. 7xl08 of those cells were mixed 
with B. 5xl07 metallic beads coated with GAM-IgG 
antibodies. After an incubation at 4°C for two 
hours, a total of 4.4xl07 cells were pulled out. 
SP2/o cells: 8.8xl06 
Fusion conditions: Fusion was done in a cell mixture 
manner. Two pulses, 2.28kVjcm and lOOJ.LSec in each 
one, were delivered. 
Feeder cells: Normal mouse red blood cells . 
Plated cells: In 352 wells, 1.5xl05 cells per well. 
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R~sults: In control groups (fusions of unsorted 
spleen cells from the same mouse and remainder 
cells) , some hybrids grew for a couple of days, then 
died. 
Fusion 6. Mouse: Balb/c 
18/09/91 Antigen: 5xl07 metallic beads that had been absorbed 
in a lysate made from WT51 B cell line cells in 
primary and secondary immunization; 2x107 WT51 cells 
in pre-fusion boost. 
Spleen cells: 2.5xl08 
Cell selection: 1.6xl08 of those spleen cells were 
mixed with sx107 metallic beads coated with GAM-IgG 
antibodies. After an incubati0n at 4°C for 1.5 hour, 
a total of 1.9xl07 cells were pulled out. 
SP2/o cells: 4xl06 
Fusion conditions: Fusion was done in a cell mixture 
manner. Two pulses, 2.17kV/cm and lOO~Sec in each 
one, were delivered. 
Feeder cells: Fresh mouse red blood cells 
Plated cells: In 152 wells, about 1.5xl05 cells per 
well. 
Results: Fusion facilities did not work properly. 
There was no growth. 
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Fusion 7: Mouse: Balbjc 
25/09/91 Antigen: 5Xl07 metallic beads that had been absorbed 
.in a lysate made from WT51 B cell line cells in 
primary and secondary immunization; 2x107 WT51 cells 
in pre-fusion boost. 
Spleen cells: 2x108 
Cell selection: 1.5x108 of those spleen cells were 
mixed with 7.5xl07 metallic beads. After an 
incubation at 4°C for one hour, a total of 1.1x107 
cells were pulled out. 
SP2/o cells: 2.5x106 
Fusion conditions: Fusion was done in a cell mixture 
manner. Two pulses, 2.19kVjcm and lOO~Sec in each 
one, were delivered. 
F~eder cells: Mouse peritoneal phagocytes 
Plated cells: In 96 wells, about 1.5xl05 cells per 
well. Half the fused cells were washed twice with 
culture medium, then plated. Another half cells were 
directly plated without washing. 
Results: In control groups (fusions of unsorted 
spleen cells from the same spleen and remainder 
cells), some hybrids grew for a couple of days, also 
culture was contaminated. 
Fusion a. Mouse: Balbjc 
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03/10/91 Antigen: 5x107 metallic beads that had been absorbed 
in a lysate made from WT51 B cell line cells in 
primary and secondary immunization; 2x107 WT51 cells 
in pre-fusion boost. 
Spleen cells: 1.6xl08 
Cell selection: 1.2x108 of those spleen cells were 
mixed with 6xlo7 metallic beads coated with GAM-IgG 
antibodies. After an incubation at 4°C for one hour, 
a total of 2.8xl07 cells were pulled out. 
SP2/o cells: 5.6xl06 
Fusion conditions: Since the number of cells was 
above the upper limit for one fusion, the cells were 
divided and each of the two halves was fused with 
SP2/o cells in a cell mixture manner. Two pulses 
were delivered to each fusion; 2 .18kV/cm and lOO,uSec 
in the first fusion, 2.14kV/cm and lOO,uSec in the 
second fusion. 
Feeder cells: Mouse peritoneal phagocytes 
Plated cells: Half the fused cells were washed with 
culture medium, then they were plated with about 
1. 5xl05 per well; another half cells were plated 
directly without washing, with about 1. 5xl05 per 
well. 
Results: No growth 
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Fusion 9. Mouse: Balbjc 
08/10/91 Antigen: 5xl07 metallic beads that had been absorbed 
in a cell lysate made from WTSl B cell line cells in 
primary and secondary immunization; 2x107 WT51 cells 
in pre-fusion boost. 
Spleen cells: 1.7xl08 
Cell selection: 1.3xl08 of those spleen cells were 
mixed with 6xl07 metallic beads coated with GAM-IgG 
antibodies. After an incubation at 4°C for one hour, 
a total of 1.5xlo7 cells were pulled out. 
SP2/o cells: 3x106 
Fusion conditions: Fusion was done in a cell mixture 
manner. Two pulses were delivered, 2.27kV/cm and 
lOO~Sec in each one. 
Feeder cells: Half the fused cells were fed with 
both mouse peritoneal phagocytes and red blood 
cells; another half cells were fed with mouse red 
blood cells only. 
Plated cells: Half the fused cells were incubated at 
37°C for 30rnin after fusion, then they were plated 
in 64 wells, about 1.5xl05 cells per well; another 
half cells, without incubation, were directly plated 
in 64 wells, about 1.5xl05 per well. 
Results: No growth in any well. 
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Fusion 10 Mouse: Balb/c 
18/10/91 Antigen: sx107 metallic beads that had been absorbed 
in a cell lysate made from WT51 B cell line cells in 
primary and secondary immunization; 2x107 WT51 cells 
in pre-fusion boost. 
Spleen cells: 1.5xlo8 
Cell Selection: About 1.2x108 of those spleen cells 
were mixed with 6x107 metallic beads coated with 
GAM-IgG antibodies. After an incubation at 4°C for 
one hour, a total of 7xl06 cells were pulled out. 
SP2/o cells: 1.5xl06 
Fusion conditions: Fusion was done in a cell mixture 
manner. Two pulses, 2.29kV/cm and lOO~Sec in each 
one, were delivered. 
Feeder cells: Normal mouse red blood cells 
Plated cells: In 56 wells, 1.5xl05 per well. After 
being plated, the cells were taken cared for by an 
experienced technician. 
Results: Some signs of hybrids, but no further 
growth. 
Fusion 11 Mouse: Balb/c 
28/10/91 Antigen: 5xl07 metallic beads that had been absorbed 
in a cell lysate made from WT51 B cell line cells in 
primary and secondary immunization; 2xl07 WT51 cells 
in pre-fusion boost. 
Spleen cells: 3.5xlo8 
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Cell selection: About 2.4xl08 of those spleen cells 
were mixed with Bxl07 metallic beads coated with 
GAM-IgG antibodies. After an incubation at 4°C for 
one hour, a total of 5.2xl06 cells were pulled out. 
SP2/o cells: 1x106 
Fusion conditions: Fusion was done in a cell mixture 
manner. ·rwo pulses, 2. 33kV/cm and lOOJ..LSec in each 
one, were delivered. 
Feeder cells: Normal mouse red blood cells 
Plated cells: The fused cells were plated in 64 
wells, less than 1x105 cells per well. In order to 
avert the negative effect of the low number of cells 
on hybrid growth, sufficient non-fused spleen cells 
were added in so that the number of 1.5xl05 cells 
were kept in each well. lx HAT medium in the first 
feeding, and l/2X HAT in the subsequent feeding were 
used. Meanwhile, a plate of SP2/o cells, as an 
indicator, were fed with the same HAT medium. When 
all these SP2/o cells were dead, The HAT medium was 
changed to HT medium. 
Results: Many hybrids grew 
Fusion 12 Mouse: Balbjc 
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07/11/91 Antigen: 5x107 metallic beads that had been absorbed 
in a cell lysate made from WT51 B cell line cells in 
primary and secondary immunization; 2x107 WT51 cells 
in pre-fusion boost. 
Spleen cells: 2.3xlo8 
Cell selection: About 1.8xl08 of those spleen cells 
were mixed with about 3.6xl07 metallic beads coated 
with GAM-IgG antibodies. After an incubation at 4°C 
for one hour, a total of 9.3xl06 cells were pulled 
out. 
SP2/o cells: 2x106 
Fusion conditions: Fusion was done in a cell mixture 
manner. Two pulses, 2.33kVjcm and lOO~Sec in each 
one, were delivered. 
Feeder cells: Normal mouse red blood cells 
Plated cells: About 1.5xl05 cells per well. lx HAT 
medium was used in the first feeding. 
Results: 5 wells in control fusion of remainder 
cells had hybrids growing. 
terminated. 
Fusion 13 Mouse: Balb/c 
The culture was 
14/11/91 Antigen: 5xl07 metallic beads that had been absorbed 
in a cell lysate made from WT51 B cell line cells in 
primary and secondary immunization; 2x107 WT51 cells 
in pre-fusion boost. 
Spleen cells: 2.98xl08 
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Cell selection: About 2.5xl08 of those spleen cells 
were mixed with 5Xl07 metallic beads coated with 
GAM-IgG antibodies. After an incubation at 4°C for 
one hour, a total of 3.5xlo6 cells were pulled out. 
SP2/o cells: About 7xlo5 
Fusion conditions: Fusion was done in a cell mixture 
manner. Two pulses, 2.33kVjcm and lOO~Sec in each 
one, were delivered. 
Feeder cells: Normal mouse red blood cells 
Plated cells: The fused cells were plated in 80 
wells, with less than 1x105 cells per well. In order 
to avert the negative effect of lower number of 
cells on hybrid growth, sufficient non-fused spleen 
cells were added so that a number of 1.5xl05 cells 
was kept in each well. lx HAT medium in the first 
feeding, and 1/2X HAT in the subsequent were used. 
Results: Many hybrids grew. 
Fusion 14 Mouse: Balb/c 
18/11/91 Antigen: 5xl07 metallic beads that had been absorbed 
in a cell lysate made from WT51 B cell line cells in 
primary; 2xl07 WT51 cells in secondary immunisation; 
5xl07 metallic beads loaded with the same molecules 
in pre-fusion boost. 
Spleen cells: 1.9xlo8 
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Cell selection: 1.5xl08 of these spleen cells were 
mixed with 5xl07 metallic beads coated with GAM-IgG 
antibodies. After an incubation at 4°C for one hour, 
a total of 7.8xl06 cells were pulled out. 
SP2/0 cells: 1.6xl06 
Fusion conditions: Fusion was done in a cell mixblre 
manner. Two pulses, 2.32kVjcm, lOO~Sec. 
Feeder cells: Normal mouse red blood cells 
Plated cells: In 96 wells, non-fused spleen cells 
were added so that each well had at least 1.5xl05 
cells. 
Results: Hybrids grew 
Fusion 15 Mouse: Balbjc 
24/01/92 Antigen: 5x107 metallic beads that had been absorbed 
in a cell lysate made from WT51 B cell line cells in 
primary and secondary immunisation; 2x1o' WT51 cells 
in pre-fusion boost. 
Spleen cells: 2.9xlo8 
Cell selection: 2.5xl08 of those spleen cells were 
mixed with 8x107 metallic beads coated with GAM-IgG 
antibodies. After an incubation at 4°C for one hour, 
a total of 1.4xl07 cells were pulled out. 
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SP2/o cells: 3xl06 
Fusion conditions: Cells in a mixture manner; two 
pulses, 182kVjcm, 100~Sec. 
Feeder cells: Normal mouse red blood cells 
Plated cells: In 112 wells, 1.5x105 cells per well. 
Results: Hybrids grew 
Fusion 16 Mouse: Balbjc 
31/01/92 Antigen: 5xl07 metallic beads that had been absorbed 
in a cell lysate made from WT51 B cell line cells in 
primary and secondary immunization; 2x107 WT51 cells 
in pre-fusion boost. 
Spl~en cells: 2.3xl08 
Cell selection: 2x1~ of those spleen cells were 
mixed with 6.5xl07 metallic beads coated with GAM-
IgG antibodies. After an incubation at 4°C for one 
hour, a total of 2.2x107 cells were pulled out. 
SP2/o cells: 4.5xl06 
Fusion conditions: Cells in a mixture manner; two 
pulses, 200kV/cm, 30~Sec. 
Feeder cells: Normal mouse red blood cells. 
Plated cells: In 192 wells, about 1.4x105 cells per 
well. 
Results: Hybrids grew. 
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Fusion 17 Mouse: Balb/c 
22/11/91 Antigen: 5x107 metallic beads that had been absorbed 
in a cell lysate made from WT51 B cell line cells in 
primary immunization; 2x107 WT51 cells in secondary 
immunization and pre-fusion boost. 
Spleen cells: 2.5xl08 
Cell selection: 2xloR of those spleen cells were 
mixed with 4xl07 metallic beads loaded with DP 
molecules. After an incubation at 4°C for one hour, 
a total of 3xl06 cells were pulled out. 
SP2/0 cells: 6xl05 
Fusion conditions: Cells in a mixture manner; two 
pulses, 2.32kV/cm, lOO~Sec. 
Feeder cells: Normal mouse red blood cells 
Plated cells: In 64 wells, non-fused spleen cells 
were added so that 1.5x105 cells were kept in each 
well. 
Results: Hybrids grew; negative in the first 
screening. 
Fusion 18 Mouse: Balb/c 
29/11/92 Antigen: 5x107 metallic beads that had bee n absorbed 
in a cell lysate made from WTSl B cell line cells in 
primary immunization; 2x107 WT51 cells in secondary 
immunization; and 5xl07 metallic beads loa ded with 
the same DP molecules in pre-fusion boost. 
Spleen cells: 1.7xl08 
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Cell selection: 1.5xl08 of those spleen cells were 
mixed with 3xl07 metallic beads loaded with DP 
molecules. After an incubation at 4°C for one hour, 
a total of 2.5xl06 cells were pulled out. 
SP2/o cells: 5xlo5 
Fusion conditions: Cells in a mixture manner; two 
pulses, 2.31kV/cm, lOO~Sec. 
Feeder cells: Normal mouse red blood cells 
Plated cells: In 32 wells, non-fused spleen cells 
Nere added so that 1.5xl05 cells were kept in each 
well. 
Results: Hybrids grew only in control fusions 
(unsorted spleen cells and remainder cells). 
Fusion 19 Mouse: Balb/c 
09/12/91 Antigen: 5xl07 metallic beads that had been absorbed 
in a cell lysate made from WT51 B cell line cells in 
primary immunization; 2x107 wT51 cells in secondary 
immunization and pre-fusion boost. 
Spleen cells: 2.7xl08 
Cell selection: 2x108 of those spleen cells were 
mixed with 4Xl07 metallic beads loaded with DP 
molecules. After an incubation at 4°C for one hour, 
a total of 3.7xl06 cells were pulled out. 
SP2/o cells: About 7.5xl05 
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Fusion conditions: In a cell mixture manner; two 
pulses, 2.31kV/cm, lOO~Sec 
Feeder cells: Normal mouse red blood cells 
Plated cells: In 84 wells, non-fused spleen cells 
were added so that 1.5xlo5 cells were kept in each 
well. 
Results: Hybrids grew; positive in the first 
screening, then contaminated. 




